United States Financial Markets News
Sign up for free!
Get instant access to all of our market news and analysis with our free REST API.
Search entities
Discover all 32,649 supported financial entities for United States financial markets here.
Latest news
Live response for past 24 hours
{
"meta": {
"found": 2279,
"returned": 10,
"limit": 10,
"page": 1
},
"data": [
{
"uuid": "da885dc9-7864-404f-aa5b-a55c3f0ba504",
"title": "Beam Therapeutics (BEAM) Gains FDA Orphan Drug Status for Sickle Cell Treatment | BEAM Stock News",
"description": "Beam Therapeutics (BEAM) has achieved a significant milestone with the U.S. Food and Drug Administration (FDA) granting orphan drug designation to its investiga",
"keywords": "GuruFocus, Article, News, GuruFocus News, BEAM",
"snippet": "Beam Therapeutics (BEAM, Financial) has achieved a significant milestone with the U.S. Food and Drug Administration (FDA) granting orphan drug designation to it...",
"url": "https://www.gurufocus.com/news/2899416/beam-therapeutics-beam-gains-fda-orphan-drug-status-for-sickle-cell-treatment-beam-stock-news",
"image_url": "https://static.gurufocus.com/logos/0C0000BPMU.png?20",
"language": "en",
"published_at": "2025-05-30T20:30:14.000000Z",
"source": "gurufocus.com",
"relevance_score": null,
"entities": [
{
"symbol": "BEAM",
"name": "Beam Therapeutics Inc.",
"exchange": null,
"exchange_long": null,
"country": "us",
"type": "equity",
"industry": "Healthcare",
"match_score": 88.249664,
"sentiment_score": 0.3184,
"highlights": [
{
"highlight": "<em>Beam</em> <em>Therapeutics</em> (BEA[+190 characters]",
"sentiment": 0.4767,
"highlighted_in": "main_text"
},
{
"highlight": "This designation is intended to support [+271 characters]",
"sentiment": 0.9274,
"highlighted_in": "main_text"
},
{
"highlight": "Wall Street Analysts Forecast\n\nBased on [+299 characters]",
"sentiment": -0.2732,
"highlighted_in": "main_text"
},
{
"highlight": "More detailed estimate data can be found[+285 characters]",
"sentiment": 0,
"highlighted_in": "main_text"
},
{
"highlight": "Based on GuruFocus estimates, the estima[+258 characters]",
"sentiment": 0.7579,
"highlighted_in": "main_text"
},
{
"highlight": "More detailed data can be found on the <[+68 characters]",
"sentiment": 0,
"highlighted_in": "main_text"
},
{
"highlight": "<em>Beam</em> <em>Therapeutics</em> (BEAM) Gains FDA Orphan Drug Status for Sickle Cell Treatment | BEAM Stock News",
"sentiment": 0.34,
"highlighted_in": "title"
}
]
}
],
"similar": [
{
"uuid": "3999edb3-e8f1-4806-a530-2941e6dc152d",
"title": "KROS: Wedbush Reiterates Neutral Rating on Keros Therapeutics | KROS Stock News",
"description": "On May 30, 2025, analyst Yun Zhong from Wedbush reiterated a \"Neutral\" rating for Keros Therapeutics (KROS) stock. The rating remains unchanged compared to prio",
"keywords": "GuruFocus, Article, News, GuruFocus News, KROS",
"snippet": "On May 30, 2025, analyst Yun Zhong from Wedbush reiterated a \"Neutral\" rating for Keros Therapeutics (KROS, Financial) stock. The rating remains unchanged compa...",
"url": "https://www.gurufocus.com/news/2898690/kros-wedbush-reiterates-neutral-rating-on-keros-therapeutics-kros-stock-news",
"image_url": "https://static.gurufocus.com/logos/0C0000BSJH.png?20",
"language": "en",
"published_at": "2025-05-30T15:00:28.000000Z",
"source": "gurufocus.com",
"relevance_score": null,
"entities": [
{
"symbol": "KROS",
"name": "Keros Therapeutics, Inc.",
"exchange": null,
"exchange_long": null,
"country": "us",
"type": "equity",
"industry": "Healthcare",
"match_score": 103.554184,
"sentiment_score": -0.05464,
"highlights": [
{
"highlight": "On May 30, 2025, analyst Yun Zhong from [+329 characters]",
"sentiment": 0,
"highlighted_in": "main_text"
},
{
"highlight": "Investors should note that the analyst r[+159 characters]",
"sentiment": 0,
"highlighted_in": "main_text"
},
{
"highlight": "Wall Street Analysts Forecast\n\nBased on [+298 characters]",
"sentiment": -0.2732,
"highlighted_in": "main_text"
},
{
"highlight": "More detailed estimate data can be found[+287 characters]",
"sentiment": 0,
"highlighted_in": "main_text"
},
{
"highlight": "KROS: Wedbush Reiterates Neutral Rating on <em>Keros</em> <em>Therapeutics</em> | KROS Stock News",
"sentiment": 0,
"highlighted_in": "title"
}
]
}
]
},
{
"uuid": "00d015eb-6b59-45e9-9290-67f15a723682",
"title": "Viridian Therapeutics to Participate in Upcoming June Investor Conferences | VRDN Stock News",
"description": "Viridian Therapeutics (VRDN) to participate in Jefferies and Goldman Sachs Global Healthcare Conferences. Webcasts of the presentations will be availabl",
"keywords": "GuruFocus, Article, News, GuruFocus News, VRDN",
"snippet": "Viridian Therapeutics (VRDN, Financial) to participate in Jefferies and Goldman Sachs Global Healthcare Conferences.\n\nWebcasts of the presentations will be avai...",
"url": "https://www.gurufocus.com/news/2898094/viridian-therapeutics-to-participate-in-upcoming-june-investor-conferences-vrdn-stock-news",
"image_url": "https://static.gurufocus.com/logos/0C0000AN0B.png?20",
"language": "en",
"published_at": "2025-05-30T12:17:59.000000Z",
"source": "gurufocus.com",
"relevance_score": null,
"entities": [
{
"symbol": "0K1R.L",
"name": "Viridian Therapeutics, Inc.",
"exchange": null,
"exchange_long": null,
"country": "gb",
"type": "equity",
"industry": "N/A",
"match_score": 85.65508,
"sentiment_score": 0.0417,
"highlights": [
{
"highlight": "<em>Viridian</em> <em>Therapeutics</em> [+350 characters]",
"sentiment": -0.0772,
"highlighted_in": "main_text"
},
{
"highlight": "As of recent, <em>Viridian</em> <em>Ther[+198 characters]",
"sentiment": 0.2023,
"highlighted_in": "main_text"
},
{
"highlight": "<em>Viridian</em> <em>Therapeutics</em> to Participate in Upcoming June Investor Conferences | VRDN Stock News",
"sentiment": 0,
"highlighted_in": "title"
}
]
},
{
"symbol": "VRDN",
"name": "Viridian Therapeutics, Inc.",
"exchange": null,
"exchange_long": null,
"country": "us",
"type": "equity",
"industry": "Healthcare",
"match_score": 85.633354,
"sentiment_score": 0.0417,
"highlights": [
{
"highlight": "<em>Viridian</em> <em>Therapeutics</em> [+350 characters]",
"sentiment": -0.0772,
"highlighted_in": "main_text"
},
{
"highlight": "As of recent, <em>Viridian</em> <em>Ther[+198 characters]",
"sentiment": 0.2023,
"highlighted_in": "main_text"
},
{
"highlight": "<em>Viridian</em> <em>Therapeutics</em> to Participate in Upcoming June Investor Conferences | VRDN Stock News",
"sentiment": 0,
"highlighted_in": "title"
}
]
}
]
},
{
"uuid": "eca5b373-67c8-4298-933f-7691c4e40c43",
"title": "Summit Therapeutics (SMMT) Surges Following HARMONi Trial Results | SMMT Stock News",
"description": "Summit Therapeutics, with the ticker SMMT, saw a significant rise of 13% in its stock price, reaching $29.79. This jump came after the company released promisin",
"keywords": "GuruFocus, Article, News, GuruFocus News, SMMT",
"snippet": "Summit Therapeutics, with the ticker SMMT, saw a significant rise of 13% in its stock price, reaching $29.79. This jump came after the company released promisin...",
"url": "https://www.gurufocus.com/news/2898036/summit-therapeutics-smmt-surges-following-harmoni-trial-results-smmt-stock-news",
"image_url": "https://static.gurufocus.com/logos/0C00000MNE.png?20",
"language": "en",
"published_at": "2025-05-30T12:01:08.000000Z",
"source": "gurufocus.com",
"relevance_score": null,
"entities": [
{
"symbol": "SMMT",
"name": "Summit Therapeutics Inc.",
"exchange": null,
"exchange_long": null,
"country": "us",
"type": "equity",
"industry": "Healthcare",
"match_score": 72.626434,
"sentiment_score": 0.14175,
"highlights": [
{
"highlight": "<em>Summit</em> <em>Therapeutics</em>, w[+313 characters]",
"sentiment": 0.8402,
"highlighted_in": "main_text"
},
{
"highlight": "Wall Street Analysts Forecast\n\nBased on [+298 characters]",
"sentiment": -0.2732,
"highlighted_in": "main_text"
},
{
"highlight": "More detailed estimate data can be found[+289 characters]",
"sentiment": 0,
"highlighted_in": "main_text"
},
{
"highlight": "<em>Summit</em> <em>Therapeutics</em> (SMMT) Surges Following HARMONi Trial Results | SMMT Stock News",
"sentiment": 0,
"highlighted_in": "title"
}
]
}
]
},
{
"uuid": "13ea9de3-7233-42c0-8bf3-8a4e87eb2feb",
"title": "Amicus Therapeutics Inc (FOLD) Announces Participation in Upcoming Investor Conferences | FOLD stock news",
"description": "Summary Amicus Therapeutics Inc (FOLD), a global biotechnology company dedicated to developing innovative medicines for rare diseases, announced on May 30, 2025",
"keywords": "GuruFocus, Article, News, GuruFocus News, FOLD",
"snippet": "Summary\n\nAmicus Therapeutics Inc (FOLD, Financial), a global biotechnology company dedicated to developing innovative medicines for rare diseases, announced on ...",
"url": "https://www.gurufocus.com/news/2898033/amicus-therapeutics-inc-fold-announces-participation-in-upcoming-investor-conferences-fold-stock-news",
"image_url": "https://static.gurufocus.com/images/global_logo_twitter_card.png",
"language": "en",
"published_at": "2025-05-30T12:01:00.000000Z",
"source": "gurufocus.com",
"relevance_score": null,
"entities": [
{
"symbol": "FOLD",
"name": "Amicus Therapeutics, Inc.",
"exchange": null,
"exchange_long": null,
"country": "us",
"type": "equity",
"industry": "Healthcare",
"match_score": 125.33801,
"sentiment_score": 0.509414,
"highlights": [
{
"highlight": "Summary\n\n<em>Amicus</em> <em>Therapeutic[+245 characters]",
"sentiment": 0.7096,
"highlighted_in": "main_text"
},
{
"highlight": "Live audio webcasts of these presentatio[+319 characters]",
"sentiment": 0.8555,
"highlighted_in": "main_text"
},
{
"highlight": "Financial Analyst Perspective\n\nFrom a fi[+281 characters]",
"sentiment": 0.8271,
"highlighted_in": "main_text"
},
{
"highlight": "Market Research Analyst Perspective\n\nAs [+242 characters]",
"sentiment": 0.8555,
"highlighted_in": "main_text"
},
{
"highlight": "FAQ\n\nQ: When and where will <em>Amicus</[+341 characters]",
"sentiment": 0,
"highlighted_in": "main_text"
},
{
"highlight": "A: The live audio webcasts can be access[+248 characters]",
"sentiment": 0.3182,
"highlighted_in": "main_text"
},
{
"highlight": "<em>Amicus</em> <em>Therapeutics</em> <em>Inc</em> (FOLD) Announces Participation in Upcoming Investor Conferences | FOLD stock news",
"sentiment": 0,
"highlighted_in": "title"
}
]
},
{
"symbol": "FOLD.MX",
"name": "Amicus Therapeutics, Inc.",
"exchange": null,
"exchange_long": null,
"country": "mx",
"type": "equity",
"industry": "Healthcare",
"match_score": 125.36324,
"sentiment_score": 0.509414,
"highlights": [
{
"highlight": "Summary\n\n<em>Amicus</em> <em>Therapeutic[+245 characters]",
"sentiment": 0.7096,
"highlighted_in": "main_text"
},
{
"highlight": "Live audio webcasts of these presentatio[+319 characters]",
"sentiment": 0.8555,
"highlighted_in": "main_text"
},
{
"highlight": "Financial Analyst Perspective\n\nFrom a fi[+281 characters]",
"sentiment": 0.8271,
"highlighted_in": "main_text"
},
{
"highlight": "Market Research Analyst Perspective\n\nAs [+242 characters]",
"sentiment": 0.8555,
"highlighted_in": "main_text"
},
{
"highlight": "FAQ\n\nQ: When and where will <em>Amicus</[+341 characters]",
"sentiment": 0,
"highlighted_in": "main_text"
},
{
"highlight": "A: The live audio webcasts can be access[+248 characters]",
"sentiment": 0.3182,
"highlighted_in": "main_text"
},
{
"highlight": "<em>Amicus</em> <em>Therapeutics</em> <em>Inc</em> (FOLD) Announces Participation in Upcoming Investor Conferences | FOLD stock news",
"sentiment": 0,
"highlighted_in": "title"
}
]
},
{
"symbol": "0HF9.L",
"name": "Amicus Therapeutics, Inc.",
"exchange": null,
"exchange_long": null,
"country": "gb",
"type": "equity",
"industry": "N/A",
"match_score": 125.357574,
"sentiment_score": 0.509414,
"highlights": [
{
"highlight": "Summary\n\n<em>Amicus</em> <em>Therapeutic[+245 characters]",
"sentiment": 0.7096,
"highlighted_in": "main_text"
},
{
"highlight": "Live audio webcasts of these presentatio[+319 characters]",
"sentiment": 0.8555,
"highlighted_in": "main_text"
},
{
"highlight": "Financial Analyst Perspective\n\nFrom a fi[+281 characters]",
"sentiment": 0.8271,
"highlighted_in": "main_text"
},
{
"highlight": "Market Research Analyst Perspective\n\nAs [+242 characters]",
"sentiment": 0.8555,
"highlighted_in": "main_text"
},
{
"highlight": "FAQ\n\nQ: When and where will <em>Amicus</[+341 characters]",
"sentiment": 0,
"highlighted_in": "main_text"
},
{
"highlight": "A: The live audio webcasts can be access[+248 characters]",
"sentiment": 0.3182,
"highlighted_in": "main_text"
},
{
"highlight": "<em>Amicus</em> <em>Therapeutics</em> <em>Inc</em> (FOLD) Announces Participation in Upcoming Investor Conferences | FOLD stock news",
"sentiment": 0,
"highlighted_in": "title"
}
]
}
]
}
]
},
{
"uuid": "16c50255-4082-4afd-8bab-748733fb1325",
"title": "Palantir Rallies on AI Deal With Fannie Mae to Fight Mortgage Fraud",
"description": "Palantir Technologies (PLTR, Financials) said Wednesday it's partnering with Fannie Mae to use artificial intelligence to detect mortgage fraud””slashing inves",
"keywords": "GuruFocus, Article, News, Faizan Farooque, PLTR",
"snippet": "Palantir Technologies (PLTR, Financials) said Wednesday it's partnering with Fannie Mae to use artificial intelligence to detect mortgage fraud—slashing inves...",
"url": "https://www.gurufocus.com/news/2899365/palantir-rallies-on-ai-deal-with-fannie-mae-to-fight-mortgage-fraud",
"image_url": "https://static.gurufocus.com/1651707455731662848.jpg",
"language": "en",
"published_at": "2025-05-30T20:25:57.000000Z",
"source": "gurufocus.com",
"relevance_score": null,
"entities": [
{
"symbol": "FMCC",
"name": "Freddie Mac",
"exchange": null,
"exchange_long": null,
"country": "us",
"type": "equity",
"industry": "Financial Services",
"match_score": 42.53128,
"sentiment_score": -0.34,
"highlights": [
{
"highlight": "William Pulte, head of the Federal Housi[+320 characters]",
"sentiment": -0.34,
"highlighted_in": "main_text"
}
]
},
{
"symbol": "FMCKL",
"name": "Freddie Mac",
"exchange": null,
"exchange_long": null,
"country": "us",
"type": "equity",
"industry": "Financial Services",
"match_score": 42.53108,
"sentiment_score": -0.34,
"highlights": [
{
"highlight": "William Pulte, head of the Federal Housi[+320 characters]",
"sentiment": -0.34,
"highlighted_in": "main_text"
}
]
},
{
"symbol": "FMCCI",
"name": "Freddie Mac",
"exchange": null,
"exchange_long": null,
"country": "us",
"type": "equity",
"industry": "Financial Services",
"match_score": 42.53108,
"sentiment_score": -0.34,
"highlights": [
{
"highlight": "William Pulte, head of the Federal Housi[+320 characters]",
"sentiment": -0.34,
"highlighted_in": "main_text"
}
]
}
],
"similar": []
},
{
"uuid": "d9f3c503-207d-49c0-a1b1-ba018d479577",
"title": "Xenon Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)",
"description": "**media[641753]**",
"keywords": "Xenon, Pharmaceuticals, Reports, Inducement, Grants, Under, Nasdaq, Listing, Rule, 5635(c)(4)",
"snippet": "VANCOUVER, British Columbia and BOSTON, May 30, 2025 (GLOBE NEWSWIRE) -- Xenon Pharmaceuticals Inc. (Nasdaq: XENE), a neuroscience-focused biopharmaceutical com...",
"url": "https://www.manilatimes.net/2025/05/31/tmt-newswire/globenewswire/xenon-pharmaceuticals-reports-inducement-grants-under-nasdaq-listing-rule-5635c4/2124380",
"image_url": "https://www.manilatimes.net/manilatimes/uploads/images/2025/05/31/641753.png",
"language": "en",
"published_at": "2025-05-30T20:06:56.000000Z",
"source": "manilatimes.net",
"relevance_score": null,
"entities": [
{
"symbol": "XENE",
"name": "Xenon Pharmaceuticals Inc.",
"exchange": null,
"exchange_long": null,
"country": "us",
"type": "equity",
"industry": "Healthcare",
"match_score": 138.27933,
"sentiment_score": 0.23936,
"highlights": [
{
"highlight": "VANCOUVER, British Columbia and BOSTON, [+86 characters]",
"sentiment": 0,
"highlighted_in": "main_text"
},
{
"highlight": "(<em>Nasdaq</em>: <em>XENE</em>), a neur[+272 characters]",
"sentiment": 0.7269,
"highlighted_in": "main_text"
},
{
"highlight": "About <em>Xenon</em> <em>Pharmaceuticals[+356 characters]",
"sentiment": -0.1779,
"highlighted_in": "main_text"
},
{
"highlight": "\"Xenon” and the Xenon logo are registe[+166 characters]",
"sentiment": 0.4215,
"highlighted_in": "main_text"
},
{
"highlight": "<em>Xenon</em> <em>Pharmaceuticals</em> Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)",
"sentiment": 0.2263,
"highlighted_in": "title"
}
]
}
],
"similar": []
},
{
"uuid": "6684f4b1-97d5-4466-9b83-3ef2094d3c58",
"title": "Kymera Therapeutics to Announce KT-621 Phase 1 Healthy Volunteer Trial Results on June 2, 2025",
"description": "**media[641752]**",
"keywords": "Kymera, Therapeutics, to, Announce, KT-621, Phase, 1, Healthy, Volunteer, Trial, Results, on, June, 2, , 2025",
"snippet": "Company to host video webcast at 8:00 a.m. ET on Monday, June 2, 2025\n\nWATERTOWN, Mass., May 30, 2025 (GLOBE NEWSWIRE) -- Kymera Therapeutics, Inc. (NASDAQ: KYM...",
"url": "https://www.manilatimes.net/2025/05/31/tmt-newswire/globenewswire/kymera-therapeutics-to-announce-kt-621-phase-1-healthy-volunteer-trial-results-on-june-2-2025/2124379",
"image_url": "https://www.manilatimes.net/manilatimes/uploads/images/2025/05/31/641752.png",
"language": "en",
"published_at": "2025-05-30T20:06:46.000000Z",
"source": "manilatimes.net",
"relevance_score": null,
"entities": [
{
"symbol": "KYMR",
"name": "Kymera Therapeutics, Inc.",
"exchange": null,
"exchange_long": null,
"country": "us",
"type": "equity",
"industry": "Healthcare",
"match_score": 87.569725,
"sentiment_score": 0.00632,
"highlights": [
{
"highlight": "., May 30, 2025 (GLOBE NEWSWIRE) -- <em>[+48 characters]",
"sentiment": 0,
"highlighted_in": "main_text"
},
{
"highlight": "(<em>NASDAQ</em>: <em>KYMR</em>), a clin[+286 characters]",
"sentiment": -0.0772,
"highlighted_in": "main_text"
},
{
"highlight": "About <em>Kymera</em> <em>Therapeutics</[+250 characters]",
"sentiment": -0.6705,
"highlighted_in": "main_text"
},
{
"highlight": "Availability of Other Information About [+209 characters]",
"sentiment": 0.3774,
"highlighted_in": "main_text"
},
{
"highlight": "<em>Kymera</em> <em>Therapeutics</em> to Announce KT-621 Phase 1 Healthy Volunteer Trial Results on June 2, 2025",
"sentiment": 0.4019,
"highlighted_in": "title"
}
]
}
],
"similar": []
},
{
"uuid": "434fe312-d75a-4b88-affb-c0a6ff820653",
"title": "Crown Holdings Inc (CCK) Expands Beverage Can Production in Brazil | CCK stock news",
"description": "Summary Crown Holdings Inc (CCK) announced on May 30, 2025, that it will be adding a new high-speed production line to its beverage can plant located in Ponta G",
"keywords": "GuruFocus, Article, News, GuruFocus News, CCK",
"snippet": "Summary\n\nCrown Holdings Inc (CCK, Financial) announced on May 30, 2025, that it will be adding a new high-speed production line to its beverage can plant locate...",
"url": "https://www.gurufocus.com/news/2899411/crown-holdings-inc-cck-expands-beverage-can-production-in-brazil-cck-stock-news",
"image_url": "https://static.gurufocus.com/images/global_logo_twitter_card.png",
"language": "en",
"published_at": "2025-05-30T20:02:06.000000Z",
"source": "gurufocus.com",
"relevance_score": null,
"entities": [
{
"symbol": "CCK",
"name": "Crown Holdings, Inc.",
"exchange": null,
"exchange_long": null,
"country": "us",
"type": "equity",
"industry": "Consumer Cyclical",
"match_score": 101.92305,
"sentiment_score": 0.407017,
"highlights": [
{
"highlight": "Summary\n\n<em>Crown</em> <em>Holdings</em[+309 characters]",
"sentiment": 0.0516,
"highlighted_in": "main_text"
},
{
"highlight": "<em>Crown</em> <em>Holdings</em> maintai[+289 characters]",
"sentiment": 0.875,
"highlighted_in": "main_text"
},
{
"highlight": "Financial Analyst Perspective\n\nFrom a fi[+200 characters]",
"sentiment": 0.4588,
"highlighted_in": "main_text"
},
{
"highlight": "Market Research Analyst Perspective\n\nAs [+175 characters]",
"sentiment": 0.2732,
"highlighted_in": "main_text"
},
{
"highlight": "Q: What is <em>Crown</em> <em>Holdings</[+256 characters]",
"sentiment": 0.6808,
"highlighted_in": "main_text"
},
{
"highlight": "<em>Crown</em> <em>Holdings</em> <em>Inc</em> (CCK) Expands Beverage Can Production in Brazil | CCK stock news",
"sentiment": 0.1027,
"highlighted_in": "title"
}
]
}
],
"similar": [
{
"uuid": "1050a225-73fe-4fe4-819b-1c3946dd2e35",
"title": "CROWN HOLDINGS, INC. TO ADD THIRD LINE TO PONTA GROSSA, BRAZIL BEVERAGE CAN PLANT",
"description": "PR NewswireTAMPA, Fla., May 30, 2025\n\n\n\nTAMPA, Fla., May 30, 2025 /PRNewswire/ -- Crown Holdings, Inc. (NYSE: CCK) announced today that the Company will add a",
"keywords": "GuruFocus, Article, News, PRNewswire, NYSE:CCK",
"snippet": "TAMPA, Fla., May 30, 2025 /PRNewswire/ -- Crown Holdings, Inc. (NYSE: CCK) announced today that the Company will add a new high-speed production line to its bev...",
"url": "https://www.gurufocus.com/news/2899314/crown-holdings-inc-to-add-third-line-to-ponta-grossa-brazil-beverage-can-plant",
"image_url": "https://static.gurufocus.com/images/global_logo_twitter_card.png",
"language": "en",
"published_at": "2025-05-30T19:00:03.000000Z",
"source": "gurufocus.com",
"relevance_score": null,
"entities": [
{
"symbol": "CCK",
"name": "Crown Holdings, Inc.",
"exchange": null,
"exchange_long": null,
"country": "us",
"type": "equity",
"industry": "Consumer Cyclical",
"match_score": 122.3746,
"sentiment_score": 0.117825,
"highlights": [
{
"highlight": "., May 30, 2025 /PRNewswire/ -- <em>Crow[+211 characters]",
"sentiment": 0,
"highlighted_in": "main_text"
},
{
"highlight": "About <em>Crown</em> <em>Holdings</em>, [+339 characters]",
"sentiment": 0.1531,
"highlighted_in": "main_text"
},
{
"highlight": "Fischer, Vice President, Investor Relati[+282 characters]",
"sentiment": 0.3182,
"highlighted_in": "main_text"
},
{
"highlight": "<em>CROWN</em> <em>HOLDINGS</em>, <em>INC</em>. TO ADD THIRD LINE TO PONTA GROSSA, BRAZIL BEVERAGE CAN PLANT",
"sentiment": 0,
"highlighted_in": "title"
}
]
},
{
"symbol": "CWN.DE",
"name": "Crown Holdings Inc.",
"exchange": null,
"exchange_long": null,
"country": "de",
"type": "equity",
"industry": "Consumer Cyclical",
"match_score": 98.77879,
"sentiment_score": 0.117825,
"highlights": [
{
"highlight": "., May 30, 2025 /PRNewswire/ -- <em>Crow[+193 characters]",
"sentiment": 0,
"highlighted_in": "main_text"
},
{
"highlight": "About <em>Crown</em> <em>Holdings</em>, [+339 characters]",
"sentiment": 0.1531,
"highlighted_in": "main_text"
},
{
"highlight": "Fischer, Vice President, Investor Relati[+282 characters]",
"sentiment": 0.3182,
"highlighted_in": "main_text"
},
{
"highlight": "<em>CROWN</em> <em>HOLDINGS</em>, <em>INC</em>. TO ADD THIRD LINE TO PONTA GROSSA, BRAZIL BEVERAGE CAN PLANT",
"sentiment": 0,
"highlighted_in": "title"
}
]
},
{
"symbol": "CCK.MX",
"name": "Crown Holdings, Inc.",
"exchange": null,
"exchange_long": null,
"country": "mx",
"type": "equity",
"industry": "Consumer Cyclical",
"match_score": 98.77388,
"sentiment_score": 0.117825,
"highlights": [
{
"highlight": "., May 30, 2025 /PRNewswire/ -- <em>Crow[+193 characters]",
"sentiment": 0,
"highlighted_in": "main_text"
},
{
"highlight": "About <em>Crown</em> <em>Holdings</em>, [+339 characters]",
"sentiment": 0.1531,
"highlighted_in": "main_text"
},
{
"highlight": "Fischer, Vice President, Investor Relati[+282 characters]",
"sentiment": 0.3182,
"highlighted_in": "main_text"
},
{
"highlight": "<em>CROWN</em> <em>HOLDINGS</em>, <em>INC</em>. TO ADD THIRD LINE TO PONTA GROSSA, BRAZIL BEVERAGE CAN PLANT",
"sentiment": 0,
"highlighted_in": "title"
}
]
},
{
"symbol": "0I4X.L",
"name": "Crown Holdings, Inc.",
"exchange": null,
"exchange_long": null,
"country": "gb",
"type": "equity",
"industry": "N/A",
"match_score": 98.77315,
"sentiment_score": 0.117825,
"highlights": [
{
"highlight": "., May 30, 2025 /PRNewswire/ -- <em>Crow[+193 characters]",
"sentiment": 0,
"highlighted_in": "main_text"
},
{
"highlight": "About <em>Crown</em> <em>Holdings</em>, [+339 characters]",
"sentiment": 0.1531,
"highlighted_in": "main_text"
},
{
"highlight": "Fischer, Vice President, Investor Relati[+282 characters]",
"sentiment": 0.3182,
"highlighted_in": "main_text"
},
{
"highlight": "<em>CROWN</em> <em>HOLDINGS</em>, <em>INC</em>. TO ADD THIRD LINE TO PONTA GROSSA, BRAZIL BEVERAGE CAN PLANT",
"sentiment": 0,
"highlighted_in": "title"
}
]
}
]
},
{
"uuid": "8d016b3f-24fa-435f-84db-ba729c4a5e4f",
"title": "Crown Holdings (CCK) Expands Production Capacity in Brazil | CCK Stock News",
"description": "Crown Holdings (CCK) is set to boost its operations in Brazil by introducing an additional high-speed production line to its beverage can factory in Ponta Gross",
"keywords": "GuruFocus, Article, News, GuruFocus News, CCK",
"snippet": "Crown Holdings (CCK, Financial) is set to boost its operations in Brazil by introducing an additional high-speed production line to its beverage can factory in ...",
"url": "https://www.gurufocus.com/news/2899275/crown-holdings-cck-expands-production-capacity-in-brazil-cck-stock-news",
"image_url": "https://static.gurufocus.com/logos/0C00000AT7.png?20",
"language": "en",
"published_at": "2025-05-30T18:30:30.000000Z",
"source": "gurufocus.com",
"relevance_score": null,
"entities": [
{
"symbol": "CCK",
"name": "Crown Holdings, Inc.",
"exchange": null,
"exchange_long": null,
"country": "us",
"type": "equity",
"industry": "Consumer Cyclical",
"match_score": 70.65677,
"sentiment_score": 0.425363,
"highlights": [
{
"highlight": "<em>Crown</em> <em>Holdings</em> (CCK, F[+324 characters]",
"sentiment": 0.4404,
"highlighted_in": "main_text"
},
{
"highlight": "Wall Street Analysts Forecast\n\nBased on [+297 characters]",
"sentiment": -0.2732,
"highlighted_in": "main_text"
},
{
"highlight": "More detailed estimate data can be found[+277 characters]",
"sentiment": 0,
"highlighted_in": "main_text"
},
{
"highlight": "Based on GuruFocus estimates, the estima[+251 characters]",
"sentiment": 0.7579,
"highlighted_in": "main_text"
},
{
"highlight": "More detailed data can be found on the <[+289 characters]",
"sentiment": 0.8402,
"highlighted_in": "main_text"
},
{
"highlight": "Positive Points\n\n<em>Crown</em> <em>Hold[+331 characters]",
"sentiment": 0.91,
"highlighted_in": "main_text"
},
{
"highlight": "<em>Crown</em> <em>Holdings</em> <em>Inc[+274 characters]",
"sentiment": 0.6249,
"highlighted_in": "main_text"
},
{
"highlight": "<em>Crown</em> <em>Holdings</em> (CCK) Expands Production Capacity in Brazil | CCK Stock News",
"sentiment": 0.1027,
"highlighted_in": "title"
}
]
},
{
"symbol": "CWN.DE",
"name": "Crown Holdings Inc.",
"exchange": null,
"exchange_long": null,
"country": "de",
"type": "equity",
"industry": "Consumer Cyclical",
"match_score": 70.65431,
"sentiment_score": 0.425363,
"highlights": [
{
"highlight": "<em>Crown</em> <em>Holdings</em> (CCK, F[+324 characters]",
"sentiment": 0.4404,
"highlighted_in": "main_text"
},
{
"highlight": "Wall Street Analysts Forecast\n\nBased on [+297 characters]",
"sentiment": -0.2732,
"highlighted_in": "main_text"
},
{
"highlight": "More detailed estimate data can be found[+277 characters]",
"sentiment": 0,
"highlighted_in": "main_text"
},
{
"highlight": "Based on GuruFocus estimates, the estima[+251 characters]",
"sentiment": 0.7579,
"highlighted_in": "main_text"
},
{
"highlight": "More detailed data can be found on the <[+289 characters]",
"sentiment": 0.8402,
"highlighted_in": "main_text"
},
{
"highlight": "Positive Points\n\n<em>Crown</em> <em>Hold[+331 characters]",
"sentiment": 0.91,
"highlighted_in": "main_text"
},
{
"highlight": "<em>Crown</em> <em>Holdings</em> <em>Inc[+274 characters]",
"sentiment": 0.6249,
"highlighted_in": "main_text"
},
{
"highlight": "<em>Crown</em> <em>Holdings</em> (CCK) Expands Production Capacity in Brazil | CCK Stock News",
"sentiment": 0.1027,
"highlighted_in": "title"
}
]
},
{
"symbol": "CCK.MX",
"name": "Crown Holdings, Inc.",
"exchange": null,
"exchange_long": null,
"country": "mx",
"type": "equity",
"industry": "Consumer Cyclical",
"match_score": 70.65174,
"sentiment_score": 0.425363,
"highlights": [
{
"highlight": "<em>Crown</em> <em>Holdings</em> (CCK, F[+324 characters]",
"sentiment": 0.4404,
"highlighted_in": "main_text"
},
{
"highlight": "Wall Street Analysts Forecast\n\nBased on [+297 characters]",
"sentiment": -0.2732,
"highlighted_in": "main_text"
},
{
"highlight": "More detailed estimate data can be found[+277 characters]",
"sentiment": 0,
"highlighted_in": "main_text"
},
{
"highlight": "Based on GuruFocus estimates, the estima[+251 characters]",
"sentiment": 0.7579,
"highlighted_in": "main_text"
},
{
"highlight": "More detailed data can be found on the <[+289 characters]",
"sentiment": 0.8402,
"highlighted_in": "main_text"
},
{
"highlight": "Positive Points\n\n<em>Crown</em> <em>Hold[+331 characters]",
"sentiment": 0.91,
"highlighted_in": "main_text"
},
{
"highlight": "<em>Crown</em> <em>Holdings</em> <em>Inc[+274 characters]",
"sentiment": 0.6249,
"highlighted_in": "main_text"
},
{
"highlight": "<em>Crown</em> <em>Holdings</em> (CCK) Expands Production Capacity in Brazil | CCK Stock News",
"sentiment": 0.1027,
"highlighted_in": "title"
}
]
},
{
"symbol": "0I4X.L",
"name": "Crown Holdings, Inc.",
"exchange": null,
"exchange_long": null,
"country": "gb",
"type": "equity",
"industry": "N/A",
"match_score": 70.65138,
"sentiment_score": 0.425363,
"highlights": [
{
"highlight": "<em>Crown</em> <em>Holdings</em> (CCK, F[+324 characters]",
"sentiment": 0.4404,
"highlighted_in": "main_text"
},
{
"highlight": "Wall Street Analysts Forecast\n\nBased on [+297 characters]",
"sentiment": -0.2732,
"highlighted_in": "main_text"
},
{
"highlight": "More detailed estimate data can be found[+277 characters]",
"sentiment": 0,
"highlighted_in": "main_text"
},
{
"highlight": "Based on GuruFocus estimates, the estima[+251 characters]",
"sentiment": 0.7579,
"highlighted_in": "main_text"
},
{
"highlight": "More detailed data can be found on the <[+289 characters]",
"sentiment": 0.8402,
"highlighted_in": "main_text"
},
{
"highlight": "Positive Points\n\n<em>Crown</em> <em>Hold[+331 characters]",
"sentiment": 0.91,
"highlighted_in": "main_text"
},
{
"highlight": "<em>Crown</em> <em>Holdings</em> <em>Inc[+274 characters]",
"sentiment": 0.6249,
"highlighted_in": "main_text"
},
{
"highlight": "<em>Crown</em> <em>Holdings</em> (CCK) Expands Production Capacity in Brazil | CCK Stock News",
"sentiment": 0.1027,
"highlighted_in": "title"
}
]
}
]
},
{
"uuid": "c320b63c-48f3-45f0-a830-343f5f473f3d",
"title": "CCK Maintains 2025 Financial Guidance with Strong Cash Flow Projections | CCK Stock News",
"description": "In a recent announcement, Crown Holdings, Inc. (CCK) reaffirmed its 2025 financial targets, projecting adjusted free cash flow to reach around $800 million. Thi",
"keywords": "GuruFocus, Article, News, GuruFocus News, CCK",
"snippet": "In a recent announcement, Crown Holdings, Inc. (CCK, Financial) reaffirmed its 2025 financial targets, projecting adjusted free cash flow to reach around $800 m...",
"url": "https://www.gurufocus.com/news/2899251/cck-maintains-2025-financial-guidance-with-strong-cash-flow-projections-cck-stock-news",
"image_url": "https://static.gurufocus.com/logos/0C00000AT7.png?20",
"language": "en",
"published_at": "2025-05-30T18:16:20.000000Z",
"source": "gurufocus.com",
"relevance_score": null,
"entities": [
{
"symbol": "CCK",
"name": "Crown Holdings, Inc.",
"exchange": null,
"exchange_long": null,
"country": "us",
"type": "equity",
"industry": "Consumer Cyclical",
"match_score": 44.294785,
"sentiment_score": 0.483786,
"highlights": [
{
"highlight": "In a recent announcement, <em>Crown</em>[+254 characters]",
"sentiment": 0.5267,
"highlighted_in": "main_text"
},
{
"highlight": "Wall Street Analysts Forecast\n\nBased on [+297 characters]",
"sentiment": -0.2732,
"highlighted_in": "main_text"
},
{
"highlight": "More detailed estimate data can be found[+277 characters]",
"sentiment": 0,
"highlighted_in": "main_text"
},
{
"highlight": "Based on GuruFocus estimates, the estima[+255 characters]",
"sentiment": 0.7579,
"highlighted_in": "main_text"
},
{
"highlight": "More detailed data can be found on the <[+289 characters]",
"sentiment": 0.8402,
"highlighted_in": "main_text"
},
{
"highlight": "Positive Points\n\n<em>Crown</em> <em>Hold[+331 characters]",
"sentiment": 0.91,
"highlighted_in": "main_text"
},
{
"highlight": "<em>Crown</em> <em>Holdings</em> <em>Inc[+274 characters]",
"sentiment": 0.6249,
"highlighted_in": "main_text"
}
]
},
{
"symbol": "CWN.DE",
"name": "Crown Holdings Inc.",
"exchange": null,
"exchange_long": null,
"country": "de",
"type": "equity",
"industry": "Consumer Cyclical",
"match_score": 44.29318,
"sentiment_score": 0.483786,
"highlights": [
{
"highlight": "In a recent announcement, <em>Crown</em>[+254 characters]",
"sentiment": 0.5267,
"highlighted_in": "main_text"
},
{
"highlight": "Wall Street Analysts Forecast\n\nBased on [+297 characters]",
"sentiment": -0.2732,
"highlighted_in": "main_text"
},
{
"highlight": "More detailed estimate data can be found[+277 characters]",
"sentiment": 0,
"highlighted_in": "main_text"
},
{
"highlight": "Based on GuruFocus estimates, the estima[+255 characters]",
"sentiment": 0.7579,
"highlighted_in": "main_text"
},
{
"highlight": "More detailed data can be found on the <[+289 characters]",
"sentiment": 0.8402,
"highlighted_in": "main_text"
},
{
"highlight": "Positive Points\n\n<em>Crown</em> <em>Hold[+331 characters]",
"sentiment": 0.91,
"highlighted_in": "main_text"
},
{
"highlight": "<em>Crown</em> <em>Holdings</em> <em>Inc[+274 characters]",
"sentiment": 0.6249,
"highlighted_in": "main_text"
}
]
},
{
"symbol": "CCK.MX",
"name": "Crown Holdings, Inc.",
"exchange": null,
"exchange_long": null,
"country": "mx",
"type": "equity",
"industry": "Consumer Cyclical",
"match_score": 44.293045,
"sentiment_score": 0.483786,
"highlights": [
{
"highlight": "In a recent announcement, <em>Crown</em>[+254 characters]",
"sentiment": 0.5267,
"highlighted_in": "main_text"
},
{
"highlight": "Wall Street Analysts Forecast\n\nBased on [+297 characters]",
"sentiment": -0.2732,
"highlighted_in": "main_text"
},
{
"highlight": "More detailed estimate data can be found[+277 characters]",
"sentiment": 0,
"highlighted_in": "main_text"
},
{
"highlight": "Based on GuruFocus estimates, the estima[+255 characters]",
"sentiment": 0.7579,
"highlighted_in": "main_text"
},
{
"highlight": "More detailed data can be found on the <[+289 characters]",
"sentiment": 0.8402,
"highlighted_in": "main_text"
},
{
"highlight": "Positive Points\n\n<em>Crown</em> <em>Hold[+331 characters]",
"sentiment": 0.91,
"highlighted_in": "main_text"
},
{
"highlight": "<em>Crown</em> <em>Holdings</em> <em>Inc[+274 characters]",
"sentiment": 0.6249,
"highlighted_in": "main_text"
}
]
},
{
"symbol": "0I4X.L",
"name": "Crown Holdings, Inc.",
"exchange": null,
"exchange_long": null,
"country": "gb",
"type": "equity",
"industry": "N/A",
"match_score": 44.293144,
"sentiment_score": 0.483786,
"highlights": [
{
"highlight": "In a recent announcement, <em>Crown</em>[+254 characters]",
"sentiment": 0.5267,
"highlighted_in": "main_text"
},
{
"highlight": "Wall Street Analysts Forecast\n\nBased on [+297 characters]",
"sentiment": -0.2732,
"highlighted_in": "main_text"
},
{
"highlight": "More detailed estimate data can be found[+277 characters]",
"sentiment": 0,
"highlighted_in": "main_text"
},
{
"highlight": "Based on GuruFocus estimates, the estima[+255 characters]",
"sentiment": 0.7579,
"highlighted_in": "main_text"
},
{
"highlight": "More detailed data can be found on the <[+289 characters]",
"sentiment": 0.8402,
"highlighted_in": "main_text"
},
{
"highlight": "Positive Points\n\n<em>Crown</em> <em>Hold[+331 characters]",
"sentiment": 0.91,
"highlighted_in": "main_text"
},
{
"highlight": "<em>Crown</em> <em>Holdings</em> <em>Inc[+274 characters]",
"sentiment": 0.6249,
"highlighted_in": "main_text"
}
]
}
]
},
{
"uuid": "8f4fc1f5-12c8-438f-a2eb-adc47ae85554",
"title": "CROWN HOLDINGS, INC. TO ADD THIRD LINE TO PONTA GROSSA, BRAZIL BEVERAGE CAN PLANT | CCK Stock News",
"description": "Crown Holdings (CCK) to expand its Ponta Grossa plant in Brazil with a third production line. Expansion will increase annual production capacity from 2.",
"keywords": "GuruFocus, Article, News, GuruFocus News, CCK",
"snippet": "Crown Holdings (CCK, Financial) to expand its Ponta Grossa plant in Brazil with a third production line.\n\nExpansion will increase annual production capacity fro...",
"url": "https://www.gurufocus.com/news/2899233/crown-holdings-inc-to-add-third-line-to-ponta-grossa-brazil-beverage-can-plant-cck-stock-news",
"image_url": "https://static.gurufocus.com/logos/0C00000AT7.png?20",
"language": "en",
"published_at": "2025-05-30T18:15:11.000000Z",
"source": "gurufocus.com",
"relevance_score": null,
"entities": [
{
"symbol": "CCK",
"name": "Crown Holdings, Inc.",
"exchange": null,
"exchange_long": null,
"country": "us",
"type": "equity",
"industry": "Consumer Cyclical",
"match_score": 90.41249,
"sentiment_score": 0.3263,
"highlights": [
{
"highlight": "<em>Crown</em> <em>Holdings</em> (CCK, F[+278 characters]",
"sentiment": 0.5574,
"highlighted_in": "main_text"
},
{
"highlight": "<em>Crown</em> <em>Holdings</em> maintai[+361 characters]",
"sentiment": 0.4215,
"highlighted_in": "main_text"
},
{
"highlight": "<em>CROWN</em> <em>HOLDINGS</em>, <em>INC</em>. TO ADD THIRD LINE TO PONTA GROSSA, BRAZIL BEVERAGE CAN PLANT | CCK Stock News",
"sentiment": 0,
"highlighted_in": "title"
}
]
},
{
"symbol": "CWN.DE",
"name": "Crown Holdings Inc.",
"exchange": null,
"exchange_long": null,
"country": "de",
"type": "equity",
"industry": "Consumer Cyclical",
"match_score": 90.40991,
"sentiment_score": 0.3263,
"highlights": [
{
"highlight": "<em>Crown</em> <em>Holdings</em> (CCK, F[+278 characters]",
"sentiment": 0.5574,
"highlighted_in": "main_text"
},
{
"highlight": "<em>Crown</em> <em>Holdings</em> maintai[+361 characters]",
"sentiment": 0.4215,
"highlighted_in": "main_text"
},
{
"highlight": "<em>CROWN</em> <em>HOLDINGS</em>, <em>INC</em>. TO ADD THIRD LINE TO PONTA GROSSA, BRAZIL BEVERAGE CAN PLANT | CCK Stock News",
"sentiment": 0,
"highlighted_in": "title"
}
]
},
{
"symbol": "CCK.MX",
"name": "Crown Holdings, Inc.",
"exchange": null,
"exchange_long": null,
"country": "mx",
"type": "equity",
"industry": "Consumer Cyclical",
"match_score": 90.40541,
"sentiment_score": 0.3263,
"highlights": [
{
"highlight": "<em>Crown</em> <em>Holdings</em> (CCK, F[+278 characters]",
"sentiment": 0.5574,
"highlighted_in": "main_text"
},
{
"highlight": "<em>Crown</em> <em>Holdings</em> maintai[+361 characters]",
"sentiment": 0.4215,
"highlighted_in": "main_text"
},
{
"highlight": "<em>CROWN</em> <em>HOLDINGS</em>, <em>INC</em>. TO ADD THIRD LINE TO PONTA GROSSA, BRAZIL BEVERAGE CAN PLANT | CCK Stock News",
"sentiment": 0,
"highlighted_in": "title"
}
]
},
{
"symbol": "0I4X.L",
"name": "Crown Holdings, Inc.",
"exchange": null,
"exchange_long": null,
"country": "gb",
"type": "equity",
"industry": "N/A",
"match_score": 90.40474,
"sentiment_score": 0.3263,
"highlights": [
{
"highlight": "<em>Crown</em> <em>Holdings</em> (CCK, F[+278 characters]",
"sentiment": 0.5574,
"highlighted_in": "main_text"
},
{
"highlight": "<em>Crown</em> <em>Holdings</em> maintai[+361 characters]",
"sentiment": 0.4215,
"highlighted_in": "main_text"
},
{
"highlight": "<em>CROWN</em> <em>HOLDINGS</em>, <em>INC</em>. TO ADD THIRD LINE TO PONTA GROSSA, BRAZIL BEVERAGE CAN PLANT | CCK Stock News",
"sentiment": 0,
"highlighted_in": "title"
}
]
}
]
}
]
},
{
"uuid": "3bc08990-35cf-4787-9517-2c14ffe10cd8",
"title": "DaVita Inc (DVA) Applauds Extension of Kidney Care Choices Model | DVA stock news",
"description": "Summary DaVita Inc (DVA), a leading comprehensive kidney care company, has expressed its support for the Center for Medicare and Medicaid Innovation's (CMMI) de",
"keywords": "GuruFocus, Article, News, GuruFocus News, DVA",
"snippet": "Summary\n\nDaVita Inc (DVA, Financial), a leading comprehensive kidney care company, has expressed its support for the Center for Medicare and Medicaid Innovation...",
"url": "https://www.gurufocus.com/news/2899410/davita-inc-dva-applauds-extension-of-kidney-care-choices-model-dva-stock-news",
"image_url": "https://static.gurufocus.com/images/global_logo_twitter_card.png",
"language": "en",
"published_at": "2025-05-30T20:01:37.000000Z",
"source": "gurufocus.com",
"relevance_score": null,
"entities": [
{
"symbol": "DVA",
"name": "DaVita Inc.",
"exchange": null,
"exchange_long": null,
"country": "us",
"type": "equity",
"industry": "Healthcare",
"match_score": 81.75696,
"sentiment_score": 0.8031,
"highlights": [
{
"highlight": "Summary\n\n<em>DaVita</em> <em>Inc</em> (D[+226 characters]",
"sentiment": 0.8957,
"highlighted_in": "main_text"
},
{
"highlight": "<em>DaVita</em>, a pioneer in this field[+281 characters]",
"sentiment": 0.93,
"highlighted_in": "main_text"
},
{
"highlight": "Q: How many Kidney Contracting Entities [+201 characters]",
"sentiment": 0.7059,
"highlighted_in": "main_text"
},
{
"highlight": "<em>DaVita</em> <em>Inc</em> (DVA) Applauds Extension of Kidney Care Choices Model | DVA stock news",
"sentiment": 0.6808,
"highlighted_in": "title"
}
]
}
],
"similar": [
{
"uuid": "c3e64285-57d1-414b-a5ce-6021dfb65c2d",
"title": "DaVita (DVA) Welcomes Extended Kidney Care Choices Model | DVA Stock News",
"description": "DaVita (DVA) recently expressed its support following the Center for Medicare and Medicaid Innovation's announcement to prolong the Kidney Care Choices Model by",
"keywords": "GuruFocus, Article, News, GuruFocus News, DVA",
"snippet": "DaVita (DVA, Financial) recently expressed its support following the Center for Medicare and Medicaid Innovation's announcement to prolong the Kidney Care Choic...",
"url": "https://www.gurufocus.com/news/2899407/davita-dva-welcomes-extended-kidney-care-choices-model-dva-stock-news",
"image_url": "https://static.gurufocus.com/logos/0C00000AVY.png?20",
"language": "en",
"published_at": "2025-05-30T20:00:32.000000Z",
"source": "gurufocus.com",
"relevance_score": null,
"entities": [
{
"symbol": "DVA",
"name": "DaVita Inc.",
"exchange": null,
"exchange_long": null,
"country": "us",
"type": "equity",
"industry": "Healthcare",
"match_score": 60.675484,
"sentiment_score": 0.673833,
"highlights": [
{
"highlight": "<em>DaVita</em> (DVA, Financial) recentl[+154 characters]",
"sentiment": 0.7096,
"highlighted_in": "main_text"
},
{
"highlight": "The Chief Transformation Officer at <em>[+301 characters]",
"sentiment": 0.765,
"highlighted_in": "main_text"
},
{
"highlight": "<em>DaVita</em> is dedicated to redefini[+321 characters]",
"sentiment": 0.6249,
"highlighted_in": "main_text"
},
{
"highlight": "More detailed estimate data can be found[+324 characters]",
"sentiment": 0.5106,
"highlighted_in": "main_text"
},
{
"highlight": "Based on GuruFocus estimates, the estima[+236 characters]",
"sentiment": 0.8176,
"highlighted_in": "main_text"
},
{
"highlight": "More detailed data can be found on the <[+305 characters]",
"sentiment": 0.2023,
"highlighted_in": "main_text"
},
{
"highlight": "Positive Points\n\n<em>DaVita</em> <em>Inc[+199 characters]",
"sentiment": 0.8807,
"highlighted_in": "main_text"
},
{
"highlight": "Despite a cybersecurity incident, <em>Da[+250 characters]",
"sentiment": 0.8442,
"highlighted_in": "main_text"
},
{
"highlight": "<em>DaVita</em> (DVA) Welcomes Extended Kidney Care Choices Model | DVA Stock News",
"sentiment": 0.7096,
"highlighted_in": "title"
}
]
},
{
"symbol": "DVA.MX",
"name": "DaVita Inc.",
"exchange": null,
"exchange_long": null,
"country": "mx",
"type": "equity",
"industry": "Healthcare",
"match_score": 60.675484,
"sentiment_score": 0.673833,
"highlights": [
{
"highlight": "<em>DaVita</em> (DVA, Financial) recentl[+154 characters]",
"sentiment": 0.7096,
"highlighted_in": "main_text"
},
{
"highlight": "The Chief Transformation Officer at <em>[+301 characters]",
"sentiment": 0.765,
"highlighted_in": "main_text"
},
{
"highlight": "<em>DaVita</em> is dedicated to redefini[+321 characters]",
"sentiment": 0.6249,
"highlighted_in": "main_text"
},
{
"highlight": "More detailed estimate data can be found[+324 characters]",
"sentiment": 0.5106,
"highlighted_in": "main_text"
},
{
"highlight": "Based on GuruFocus estimates, the estima[+236 characters]",
"sentiment": 0.8176,
"highlighted_in": "main_text"
},
{
"highlight": "More detailed data can be found on the <[+305 characters]",
"sentiment": 0.2023,
"highlighted_in": "main_text"
},
{
"highlight": "Positive Points\n\n<em>DaVita</em> <em>Inc[+199 characters]",
"sentiment": 0.8807,
"highlighted_in": "main_text"
},
{
"highlight": "Despite a cybersecurity incident, <em>Da[+250 characters]",
"sentiment": 0.8442,
"highlighted_in": "main_text"
},
{
"highlight": "<em>DaVita</em> (DVA) Welcomes Extended Kidney Care Choices Model | DVA Stock News",
"sentiment": 0.7096,
"highlighted_in": "title"
}
]
},
{
"symbol": "0I7E.L",
"name": "DaVita Inc.",
"exchange": null,
"exchange_long": null,
"country": "gb",
"type": "equity",
"industry": "N/A",
"match_score": 60.64231,
"sentiment_score": 0.673833,
"highlights": [
{
"highlight": "<em>DaVita</em> (DVA, Financial) recentl[+154 characters]",
"sentiment": 0.7096,
"highlighted_in": "main_text"
},
{
"highlight": "The Chief Transformation Officer at <em>[+301 characters]",
"sentiment": 0.765,
"highlighted_in": "main_text"
},
{
"highlight": "<em>DaVita</em> is dedicated to redefini[+321 characters]",
"sentiment": 0.6249,
"highlighted_in": "main_text"
},
{
"highlight": "More detailed estimate data can be found[+324 characters]",
"sentiment": 0.5106,
"highlighted_in": "main_text"
},
{
"highlight": "Based on GuruFocus estimates, the estima[+236 characters]",
"sentiment": 0.8176,
"highlighted_in": "main_text"
},
{
"highlight": "More detailed data can be found on the <[+305 characters]",
"sentiment": 0.2023,
"highlighted_in": "main_text"
},
{
"highlight": "Positive Points\n\n<em>DaVita</em> <em>Inc[+199 characters]",
"sentiment": 0.8807,
"highlighted_in": "main_text"
},
{
"highlight": "Despite a cybersecurity incident, <em>Da[+250 characters]",
"sentiment": 0.8442,
"highlighted_in": "main_text"
},
{
"highlight": "<em>DaVita</em> (DVA) Welcomes Extended Kidney Care Choices Model | DVA Stock News",
"sentiment": 0.7096,
"highlighted_in": "title"
}
]
},
{
"symbol": "DVAI34.SA",
"name": "DaVita Inc.",
"exchange": null,
"exchange_long": null,
"country": "br",
"type": "equity",
"industry": "Healthcare",
"match_score": 60.626213,
"sentiment_score": 0.673833,
"highlights": [
{
"highlight": "<em>DaVita</em> (DVA, Financial) recentl[+154 characters]",
"sentiment": 0.7096,
"highlighted_in": "main_text"
},
{
"highlight": "The Chief Transformation Officer at <em>[+301 characters]",
"sentiment": 0.765,
"highlighted_in": "main_text"
},
{
"highlight": "<em>DaVita</em> is dedicated to redefini[+321 characters]",
"sentiment": 0.6249,
"highlighted_in": "main_text"
},
{
"highlight": "More detailed estimate data can be found[+324 characters]",
"sentiment": 0.5106,
"highlighted_in": "main_text"
},
{
"highlight": "Based on GuruFocus estimates, the estima[+236 characters]",
"sentiment": 0.8176,
"highlighted_in": "main_text"
},
{
"highlight": "More detailed data can be found on the <[+305 characters]",
"sentiment": 0.2023,
"highlighted_in": "main_text"
},
{
"highlight": "Positive Points\n\n<em>DaVita</em> <em>Inc[+199 characters]",
"sentiment": 0.8807,
"highlighted_in": "main_text"
},
{
"highlight": "Despite a cybersecurity incident, <em>Da[+250 characters]",
"sentiment": 0.8442,
"highlighted_in": "main_text"
},
{
"highlight": "<em>DaVita</em> (DVA) Welcomes Extended Kidney Care Choices Model | DVA Stock News",
"sentiment": 0.7096,
"highlighted_in": "title"
}
]
}
]
},
{
"uuid": "44de1e58-d27b-4127-aa2d-218370af8f0d",
"title": "DaVita Statement on Government's Kidney Care Choices (KCC) Model Updates",
"description": "PR NewswireDENVER, May 30, 2025\n\n\n\nDENVER, May 30, 2025 /PRNewswire/ -- DaVita, a comprehensive kidney care company, issued the following statement in respons",
"keywords": "GuruFocus, Article, News, PRNewswire, NYSE:DVA",
"snippet": "DENVER, May 30, 2025 /PRNewswire/ -- DaVita, a comprehensive kidney care company, issued the following statement in response to updates this week from the Cente...",
"url": "https://www.gurufocus.com/news/2899400/davita-statement-on-governments-kidney-care-choices-kcc-model-updates",
"image_url": "https://static.gurufocus.com/images/global_logo_twitter_card.png",
"language": "en",
"published_at": "2025-05-30T20:00:03.000000Z",
"source": "gurufocus.com",
"relevance_score": null,
"entities": [
{
"symbol": "DVA",
"name": "DaVita Inc.",
"exchange": null,
"exchange_long": null,
"country": "us",
"type": "equity",
"industry": "Healthcare",
"match_score": 71.53648,
"sentiment_score": 0.727188,
"highlights": [
{
"highlight": "DENVER, May 30, 2025 /PRNewswire/ -- <em[+311 characters]",
"sentiment": 0.875,
"highlighted_in": "main_text"
},
{
"highlight": "<em>DaVita</em> is committed to establis[+292 characters]",
"sentiment": 0.9042,
"highlighted_in": "main_text"
},
{
"highlight": "To learn more about <em>DaVita</em> Inte[+255 characters]",
"sentiment": 0.9337,
"highlighted_in": "main_text"
},
{
"highlight": "As a comprehensive kidney care provider,[+313 characters]",
"sentiment": 0.9509,
"highlighted_in": "main_text"
},
{
"highlight": "As of March 31, 2025, <em>DaVita</em> se[+192 characters]",
"sentiment": 0.4215,
"highlighted_in": "main_text"
},
{
"highlight": "<em>DaVita</em> has reduced hospitalizat[+229 characters]",
"sentiment": 0.9201,
"highlighted_in": "main_text"
},
{
"highlight": "Media Contact\n\n[email protected]\n\nView o[+174 characters]",
"sentiment": 0.3182,
"highlighted_in": "main_text"
},
{
"highlight": "<em>DaVita</em> Statement on Government's Kidney Care Choices (KCC) Model Updates",
"sentiment": 0.4939,
"highlighted_in": "title"
}
]
},
{
"symbol": "DVA.MX",
"name": "DaVita Inc.",
"exchange": null,
"exchange_long": null,
"country": "mx",
"type": "equity",
"industry": "Healthcare",
"match_score": 52.57196,
"sentiment_score": 0.727188,
"highlights": [
{
"highlight": "DENVER, May 30, 2025 /PRNewswire/ -- <em[+311 characters]",
"sentiment": 0.875,
"highlighted_in": "main_text"
},
{
"highlight": "<em>DaVita</em> is committed to establis[+292 characters]",
"sentiment": 0.9042,
"highlighted_in": "main_text"
},
{
"highlight": "To learn more about <em>DaVita</em> Inte[+237 characters]",
"sentiment": 0.9337,
"highlighted_in": "main_text"
},
{
"highlight": "As a comprehensive kidney care provider,[+313 characters]",
"sentiment": 0.9509,
"highlighted_in": "main_text"
},
{
"highlight": "As of March 31, 2025, <em>DaVita</em> se[+192 characters]",
"sentiment": 0.4215,
"highlighted_in": "main_text"
},
{
"highlight": "<em>DaVita</em> has reduced hospitalizat[+229 characters]",
"sentiment": 0.9201,
"highlighted_in": "main_text"
},
{
"highlight": "Media Contact\n\n[email protected]\n\nView o[+174 characters]",
"sentiment": 0.3182,
"highlighted_in": "main_text"
},
{
"highlight": "<em>DaVita</em> Statement on Government's Kidney Care Choices (KCC) Model Updates",
"sentiment": 0.4939,
"highlighted_in": "title"
}
]
},
{
"symbol": "0I7E.L",
"name": "DaVita Inc.",
"exchange": null,
"exchange_long": null,
"country": "gb",
"type": "equity",
"industry": "N/A",
"match_score": 52.540432,
"sentiment_score": 0.727188,
"highlights": [
{
"highlight": "DENVER, May 30, 2025 /PRNewswire/ -- <em[+311 characters]",
"sentiment": 0.875,
"highlighted_in": "main_text"
},
{
"highlight": "<em>DaVita</em> is committed to establis[+292 characters]",
"sentiment": 0.9042,
"highlighted_in": "main_text"
},
{
"highlight": "To learn more about <em>DaVita</em> Inte[+237 characters]",
"sentiment": 0.9337,
"highlighted_in": "main_text"
},
{
"highlight": "As a comprehensive kidney care provider,[+313 characters]",
"sentiment": 0.9509,
"highlighted_in": "main_text"
},
{
"highlight": "As of March 31, 2025, <em>DaVita</em> se[+192 characters]",
"sentiment": 0.4215,
"highlighted_in": "main_text"
},
{
"highlight": "<em>DaVita</em> has reduced hospitalizat[+229 characters]",
"sentiment": 0.9201,
"highlighted_in": "main_text"
},
{
"highlight": "Media Contact\n\n[email protected]\n\nView o[+174 characters]",
"sentiment": 0.3182,
"highlighted_in": "main_text"
},
{
"highlight": "<em>DaVita</em> Statement on Government's Kidney Care Choices (KCC) Model Updates",
"sentiment": 0.4939,
"highlighted_in": "title"
}
]
},
{
"symbol": "DVAI34.SA",
"name": "DaVita Inc.",
"exchange": null,
"exchange_long": null,
"country": "br",
"type": "equity",
"industry": "Healthcare",
"match_score": 52.525063,
"sentiment_score": 0.727188,
"highlights": [
{
"highlight": "DENVER, May 30, 2025 /PRNewswire/ -- <em[+311 characters]",
"sentiment": 0.875,
"highlighted_in": "main_text"
},
{
"highlight": "<em>DaVita</em> is committed to establis[+292 characters]",
"sentiment": 0.9042,
"highlighted_in": "main_text"
},
{
"highlight": "To learn more about <em>DaVita</em> Inte[+237 characters]",
"sentiment": 0.9337,
"highlighted_in": "main_text"
},
{
"highlight": "As a comprehensive kidney care provider,[+313 characters]",
"sentiment": 0.9509,
"highlighted_in": "main_text"
},
{
"highlight": "As of March 31, 2025, <em>DaVita</em> se[+192 characters]",
"sentiment": 0.4215,
"highlighted_in": "main_text"
},
{
"highlight": "<em>DaVita</em> has reduced hospitalizat[+229 characters]",
"sentiment": 0.9201,
"highlighted_in": "main_text"
},
{
"highlight": "Media Contact\n\n[email protected]\n\nView o[+174 characters]",
"sentiment": 0.3182,
"highlighted_in": "main_text"
},
{
"highlight": "<em>DaVita</em> Statement on Government's Kidney Care Choices (KCC) Model Updates",
"sentiment": 0.4939,
"highlighted_in": "title"
}
]
}
]
},
{
"uuid": "6f09730f-80b6-4bd0-ab4b-905c5a2d1374",
"title": "DaVita Statement on Government's Kidney Care Choices (KCC) Model Updates | DVA Stock News",
"description": "The Center for Medicare and Medicaid Innovation (CMMI) has extended the Kidney Care Choices (KCC) Model for an additional year, benefitting DaVita's (DVA)",
"keywords": "GuruFocus, Article, News, GuruFocus News, DVA",
"snippet": "The Center for Medicare and Medicaid Innovation (CMMI) has extended the Kidney Care Choices (KCC) Model for an additional year, benefitting DaVita's (DVA, Finan...",
"url": "https://www.gurufocus.com/news/2899370/davita-statement-on-governments-kidney-care-choices-kcc-model-updates-dva-stock-news",
"image_url": "https://static.gurufocus.com/logos/0C00000AVY.png?20",
"language": "en",
"published_at": "2025-05-30T19:45:23.000000Z",
"source": "gurufocus.com",
"relevance_score": null,
"entities": [
{
"symbol": "DVA",
"name": "DaVita Inc.",
"exchange": null,
"exchange_long": null,
"country": "us",
"type": "equity",
"industry": "Healthcare",
"match_score": 51.701687,
"sentiment_score": 0.612833,
"highlights": [
{
"highlight": "<em>DaVita</em> has expanded its value-b[+270 characters]",
"sentiment": 0.9231,
"highlighted_in": "main_text"
},
{
"highlight": "As of March 31, 2025, <em>DaVita</em> se[+181 characters]",
"sentiment": 0.4215,
"highlighted_in": "main_text"
},
{
"highlight": "<em>DaVita</em> Statement on Government's Kidney Care Choices (KCC) Model Updates | DVA Stock News",
"sentiment": 0.4939,
"highlighted_in": "title"
}
]
},
{
"symbol": "DVA.MX",
"name": "DaVita Inc.",
"exchange": null,
"exchange_long": null,
"country": "mx",
"type": "equity",
"industry": "Healthcare",
"match_score": 51.701687,
"sentiment_score": 0.612833,
"highlights": [
{
"highlight": "<em>DaVita</em> has expanded its value-b[+270 characters]",
"sentiment": 0.9231,
"highlighted_in": "main_text"
},
{
"highlight": "As of March 31, 2025, <em>DaVita</em> se[+181 characters]",
"sentiment": 0.4215,
"highlighted_in": "main_text"
},
{
"highlight": "<em>DaVita</em> Statement on Government's Kidney Care Choices (KCC) Model Updates | DVA Stock News",
"sentiment": 0.4939,
"highlighted_in": "title"
}
]
},
{
"symbol": "0I7E.L",
"name": "DaVita Inc.",
"exchange": null,
"exchange_long": null,
"country": "gb",
"type": "equity",
"industry": "N/A",
"match_score": 51.672073,
"sentiment_score": 0.612833,
"highlights": [
{
"highlight": "<em>DaVita</em> has expanded its value-b[+270 characters]",
"sentiment": 0.9231,
"highlighted_in": "main_text"
},
{
"highlight": "As of March 31, 2025, <em>DaVita</em> se[+181 characters]",
"sentiment": 0.4215,
"highlighted_in": "main_text"
},
{
"highlight": "<em>DaVita</em> Statement on Government's Kidney Care Choices (KCC) Model Updates | DVA Stock News",
"sentiment": 0.4939,
"highlighted_in": "title"
}
]
},
{
"symbol": "DVAI34.SA",
"name": "DaVita Inc.",
"exchange": null,
"exchange_long": null,
"country": "br",
"type": "equity",
"industry": "Healthcare",
"match_score": 51.65766,
"sentiment_score": 0.612833,
"highlights": [
{
"highlight": "<em>DaVita</em> has expanded its value-b[+270 characters]",
"sentiment": 0.9231,
"highlighted_in": "main_text"
},
{
"highlight": "As of March 31, 2025, <em>DaVita</em> se[+181 characters]",
"sentiment": 0.4215,
"highlighted_in": "main_text"
},
{
"highlight": "<em>DaVita</em> Statement on Government's Kidney Care Choices (KCC) Model Updates | DVA Stock News",
"sentiment": 0.4939,
"highlighted_in": "title"
}
]
}
]
}
]
},
{
"uuid": "c2a09de8-42c3-460d-9186-6f5a8791ab1a",
"title": "Regeneron Pharmaceuticals (REGN) Faces Rating Downgrade by Wells Fargo | REGN Stock News",
"description": "In a recent development, Regeneron Pharmaceuticals (REGN) has been downgraded by Wells Fargo. The analyst behind this change, Mohit Bansal, has adjusted the com",
"keywords": "GuruFocus, Article, News, GuruFocus News, REGN",
"snippet": "In a recent development, Regeneron Pharmaceuticals (REGN, Financial) has been downgraded by Wells Fargo. The analyst behind this change, Mohit Bansal, has adjus...",
"url": "https://www.gurufocus.com/news/2899403/regeneron-pharmaceuticals-regn-faces-rating-downgrade-by-wells-fargo-regn-stock-news",
"image_url": "https://static.gurufocus.com/logos/0C000008R4.png?20",
"language": "en",
"published_at": "2025-05-30T20:00:15.000000Z",
"source": "gurufocus.com",
"relevance_score": null,
"entities": [
{
"symbol": "REGN",
"name": "Regeneron Pharmaceuticals, Inc.",
"exchange": null,
"exchange_long": null,
"country": "us",
"type": "equity",
"industry": "Healthcare",
"match_score": 89.57759,
"sentiment_score": 0.196788,
"highlights": [
{
"highlight": "In a recent development, <em>Regeneron</[+303 characters]",
"sentiment": 0.25,
"highlighted_in": "main_text"
},
{
"highlight": "In addition to the rating downgrade, Wel[+307 characters]",
"sentiment": 0.128,
"highlighted_in": "main_text"
},
{
"highlight": "Investors in <em>Regeneron</em> <em>Phar[+127 characters]",
"sentiment": 0.4019,
"highlighted_in": "main_text"
},
{
"highlight": "Wall Street Analysts Forecast\n\nBased on [+312 characters]",
"sentiment": -0.2732,
"highlighted_in": "main_text"
},
{
"highlight": "More detailed estimate data can be found[+301 characters]",
"sentiment": 0,
"highlighted_in": "main_text"
},
{
"highlight": "Based on GuruFocus estimates, the estima[+265 characters]",
"sentiment": 0.8176,
"highlighted_in": "main_text"
},
{
"highlight": "More detailed data can be found on the <[+76 characters]",
"sentiment": 0,
"highlighted_in": "main_text"
},
{
"highlight": "<em>Regeneron</em> <em>Pharmaceuticals</em> (REGN) Faces Rating Downgrade by Wells Fargo | REGN Stock News",
"sentiment": 0.25,
"highlighted_in": "title"
}
]
}
],
"similar": [
{
"uuid": "24916739-ebba-4b72-9a99-5b21fccc0af4",
"title": "Regeneron (REGN) Downgraded by RBC Capital with Adjusted Price Target | REGN Stock News",
"description": "RBC Capital's analyst, Brian Abrahams, has adjusted his outlook on Regeneron (REGN), moving it from an",
"keywords": "GuruFocus, Article, News, GuruFocus News, REGN",
"snippet": "RBC Capital's analyst, Brian Abrahams, has adjusted his outlook on Regeneron (REGN, Financial), moving it from an \"Outperform\" rating to a \"Sector Perform\" desi...",
"url": "https://www.gurufocus.com/news/2898947/regeneron-regn-downgraded-by-rbc-capital-with-adjusted-price-target-regn-stock-news",
"image_url": "https://static.gurufocus.com/logos/0C000008R4.png?20",
"language": "en",
"published_at": "2025-05-30T17:30:12.000000Z",
"source": "gurufocus.com",
"relevance_score": null,
"entities": [
{
"symbol": "REGN34.SA",
"name": "Regeneron Pharmaceuticals, Inc.",
"exchange": null,
"exchange_long": null,
"country": "br",
"type": "equity",
"industry": "Healthcare",
"match_score": 59.00975,
"sentiment_score": 0.11404,
"highlights": [
{
"highlight": "Wall Street Analysts Forecast\n\nBased on [+312 characters]",
"sentiment": -0.2732,
"highlighted_in": "main_text"
},
{
"highlight": "More detailed estimate data can be found[+301 characters]",
"sentiment": 0,
"highlighted_in": "main_text"
},
{
"highlight": "Based on GuruFocus estimates, the estima[+268 characters]",
"sentiment": 0.8176,
"highlighted_in": "main_text"
},
{
"highlight": "More detailed data can be found on the <[+320 characters]",
"sentiment": 0,
"highlighted_in": "main_text"
},
{
"highlight": "<em>Regeneron</em> <em>Pharmaceuticals</[+332 characters]",
"sentiment": 0.0258,
"highlighted_in": "main_text"
}
]
},
{
"symbol": "REGN",
"name": "Regeneron Pharmaceuticals, Inc.",
"exchange": null,
"exchange_long": null,
"country": "us",
"type": "equity",
"industry": "Healthcare",
"match_score": 59.007187,
"sentiment_score": 0.11404,
"highlights": [
{
"highlight": "Wall Street Analysts Forecast\n\nBased on [+312 characters]",
"sentiment": -0.2732,
"highlighted_in": "main_text"
},
{
"highlight": "More detailed estimate data can be found[+301 characters]",
"sentiment": 0,
"highlighted_in": "main_text"
},
{
"highlight": "Based on GuruFocus estimates, the estima[+268 characters]",
"sentiment": 0.8176,
"highlighted_in": "main_text"
},
{
"highlight": "More detailed data can be found on the <[+320 characters]",
"sentiment": 0,
"highlighted_in": "main_text"
},
{
"highlight": "<em>Regeneron</em> <em>Pharmaceuticals</[+332 characters]",
"sentiment": 0.0258,
"highlighted_in": "main_text"
}
]
},
{
"symbol": "REGN.MX",
"name": "Regeneron Pharmaceuticals, Inc.",
"exchange": null,
"exchange_long": null,
"country": "mx",
"type": "equity",
"industry": "Healthcare",
"match_score": 58.995926,
"sentiment_score": 0.11404,
"highlights": [
{
"highlight": "Wall Street Analysts Forecast\n\nBased on [+312 characters]",
"sentiment": -0.2732,
"highlighted_in": "main_text"
},
{
"highlight": "More detailed estimate data can be found[+301 characters]",
"sentiment": 0,
"highlighted_in": "main_text"
},
{
"highlight": "Based on GuruFocus estimates, the estima[+268 characters]",
"sentiment": 0.8176,
"highlighted_in": "main_text"
},
{
"highlight": "More detailed data can be found on the <[+320 characters]",
"sentiment": 0,
"highlighted_in": "main_text"
},
{
"highlight": "<em>Regeneron</em> <em>Pharmaceuticals</[+332 characters]",
"sentiment": 0.0258,
"highlighted_in": "main_text"
}
]
},
{
"symbol": "0R2M.L",
"name": "Regeneron Pharmaceuticals, Inc.",
"exchange": null,
"exchange_long": null,
"country": "gb",
"type": "equity",
"industry": "N/A",
"match_score": 58.99276,
"sentiment_score": 0.11404,
"highlights": [
{
"highlight": "Wall Street Analysts Forecast\n\nBased on [+312 characters]",
"sentiment": -0.2732,
"highlighted_in": "main_text"
},
{
"highlight": "More detailed estimate data can be found[+301 characters]",
"sentiment": 0,
"highlighted_in": "main_text"
},
{
"highlight": "Based on GuruFocus estimates, the estima[+268 characters]",
"sentiment": 0.8176,
"highlighted_in": "main_text"
},
{
"highlight": "More detailed data can be found on the <[+320 characters]",
"sentiment": 0,
"highlighted_in": "main_text"
},
{
"highlight": "<em>Regeneron</em> <em>Pharmaceuticals</[+332 characters]",
"sentiment": 0.0258,
"highlighted_in": "main_text"
}
]
}
]
},
{
"uuid": "6a1f0528-f651-4baf-83b6-a65cf11e018b",
"title": "Regeneron (REGN) Faces Setback with Phase 3 Trial Failure",
"description": "Key Highlights:\n Regeneron (REGN) shares fell by nearly 18% after a Phase 3 trial setback. Despite the drop, analysts' average target price suggests significa",
"keywords": "GuruFocus, Article, News, GuruFocus News, REGN",
"snippet": "Key Highlights:\n\nRegeneron (REGN, Financial) shares fell by nearly 18% after a Phase 3 trial setback.\n\nDespite the drop, analysts' average target price suggests...",
"url": "https://www.gurufocus.com/news/2898870/regeneron-regn-faces-setback-with-phase-3-trial-failure",
"image_url": "https://static.gurufocus.com/logos/0C000008R4.png?20",
"language": "en",
"published_at": "2025-05-30T16:55:46.000000Z",
"source": "gurufocus.com",
"relevance_score": null,
"entities": [
{
"symbol": "REGN",
"name": "Regeneron Pharmaceuticals, Inc.",
"exchange": null,
"exchange_long": null,
"country": "us",
"type": "equity",
"industry": "Healthcare",
"match_score": 57.591366,
"sentiment_score": 0.370167,
"highlights": [
{
"highlight": "Regeneron's Recent Market Turbulence\n\n<e[+334 characters]",
"sentiment": 0.5423,
"highlighted_in": "main_text"
},
{
"highlight": "For an in-depth look at these estimates,[+310 characters]",
"sentiment": 0.3182,
"highlighted_in": "main_text"
},
{
"highlight": "For a comprehensive overview of Regenero[+113 characters]",
"sentiment": 0.25,
"highlighted_in": "main_text"
}
]
},
{
"symbol": "REGN.MX",
"name": "Regeneron Pharmaceuticals, Inc.",
"exchange": null,
"exchange_long": null,
"country": "mx",
"type": "equity",
"industry": "Healthcare",
"match_score": 57.590607,
"sentiment_score": 0.370167,
"highlights": [
{
"highlight": "Regeneron's Recent Market Turbulence\n\n<e[+334 characters]",
"sentiment": 0.5423,
"highlighted_in": "main_text"
},
{
"highlight": "For an in-depth look at these estimates,[+310 characters]",
"sentiment": 0.3182,
"highlighted_in": "main_text"
},
{
"highlight": "For a comprehensive overview of Regenero[+113 characters]",
"sentiment": 0.25,
"highlighted_in": "main_text"
}
]
},
{
"symbol": "0R2M.L",
"name": "Regeneron Pharmaceuticals, Inc.",
"exchange": null,
"exchange_long": null,
"country": "gb",
"type": "equity",
"industry": "N/A",
"match_score": 57.61004,
"sentiment_score": 0.370167,
"highlights": [
{
"highlight": "Regeneron's Recent Market Turbulence\n\n<e[+334 characters]",
"sentiment": 0.5423,
"highlighted_in": "main_text"
},
{
"highlight": "For an in-depth look at these estimates,[+310 characters]",
"sentiment": 0.3182,
"highlighted_in": "main_text"
},
{
"highlight": "For a comprehensive overview of Regenero[+113 characters]",
"sentiment": 0.25,
"highlighted_in": "main_text"
}
]
},
{
"symbol": "REGN34.SA",
"name": "Regeneron Pharmaceuticals, Inc.",
"exchange": null,
"exchange_long": null,
"country": "br",
"type": "equity",
"industry": "Healthcare",
"match_score": 57.615814,
"sentiment_score": 0.370167,
"highlights": [
{
"highlight": "Regeneron's Recent Market Turbulence\n\n<e[+334 characters]",
"sentiment": 0.5423,
"highlighted_in": "main_text"
},
{
"highlight": "For an in-depth look at these estimates,[+310 characters]",
"sentiment": 0.3182,
"highlighted_in": "main_text"
},
{
"highlight": "For a comprehensive overview of Regenero[+113 characters]",
"sentiment": 0.25,
"highlighted_in": "main_text"
}
]
}
]
},
{
"uuid": "57286a5f-18e8-419b-a5ed-058403a045c8",
"title": "Rocket Pharmaceuticals (RCKT) Faces Downgrade with New Price Target | RCKT Stock News",
"description": "Evercore ISI analyst Gavin Clark-Gartner has revised his recommendation for Rocket Pharmaceuticals (RCKT), moving it from an Outperform rating to In Line. The u",
"keywords": "GuruFocus, Article, News, GuruFocus News, RCKT",
"snippet": "Evercore ISI analyst Gavin Clark-Gartner has revised his recommendation for Rocket Pharmaceuticals (RCKT, Financial), moving it from an Outperform rating to In ...",
"url": "https://www.gurufocus.com/news/2898720/rocket-pharmaceuticals-rckt-faces-downgrade-with-new-price-target-rckt-stock-news",
"image_url": "https://static.gurufocus.com/logos/0C0000ARJR.png?20",
"language": "en",
"published_at": "2025-05-30T15:15:30.000000Z",
"source": "gurufocus.com",
"relevance_score": null,
"entities": [
{
"symbol": "RCKT",
"name": "Rocket Pharmaceuticals, Inc.",
"exchange": null,
"exchange_long": null,
"country": "us",
"type": "equity",
"industry": "Healthcare",
"match_score": 76.127045,
"sentiment_score": -0.0683,
"highlights": [
{
"highlight": "Evercore ISI analyst Gavin Clark-Gartner[+314 characters]",
"sentiment": 0,
"highlighted_in": "main_text"
},
{
"highlight": "Wall Street Analysts Forecast\n\nBased on [+302 characters]",
"sentiment": -0.2732,
"highlighted_in": "main_text"
},
{
"highlight": "More detailed estimate data can be found[+295 characters]",
"sentiment": 0,
"highlighted_in": "main_text"
},
{
"highlight": "<em>Rocket</em> <em>Pharmaceuticals</em> (RCKT) Faces Downgrade with New Price Target | RCKT Stock News",
"sentiment": 0,
"highlighted_in": "title"
}
]
}
]
},
{
"uuid": "164ce8d9-5f3c-44c3-a39c-88d9a64912aa",
"title": "NTAP: Wells Fargo Lowers NetApp Price Target, Maintains Rating | NTAP Stock News",
"description": "Wells Fargo analyst Aaron Rakers has adjusted the price target for NetApp (NTAP), lowering it from $115.00 to $100.00. This change reflects a decrease of 13.04%",
"keywords": "GuruFocus, Article, News, GuruFocus News, NTAP",
"snippet": "Wells Fargo analyst Aaron Rakers has adjusted the price target for NetApp (NTAP, Financial), lowering it from $115.00 to $100.00. This change reflects a decreas...",
"url": "https://www.gurufocus.com/news/2898710/ntap-wells-fargo-lowers-netapp-price-target-maintains-rating-ntap-stock-news",
"image_url": "https://static.gurufocus.com/logos/0C00000BS6.png?20",
"language": "en",
"published_at": "2025-05-30T15:02:20.000000Z",
"source": "gurufocus.com",
"relevance_score": null,
"entities": [
{
"symbol": "N1TA34.SA",
"name": "NetApp, Inc.",
"exchange": null,
"exchange_long": null,
"country": "br",
"type": "equity",
"industry": "Technology",
"match_score": 55.795135,
"sentiment_score": 0.236729,
"highlights": [
{
"highlight": "Wells Fargo analyst Aaron Rakers has adj[+318 characters]",
"sentiment": 0.2838,
"highlighted_in": "main_text"
},
{
"highlight": "<em>NetApp</em> (NTAP, Financial) is lis[+185 characters]",
"sentiment": 0.25,
"highlighted_in": "main_text"
},
{
"highlight": "Wall Street Analysts Forecast\n\nBased on [+281 characters]",
"sentiment": -0.2732,
"highlighted_in": "main_text"
},
{
"highlight": "More detailed estimate data can be found[+326 characters]",
"sentiment": 0.5106,
"highlighted_in": "main_text"
},
{
"highlight": "Based on GuruFocus estimates, the estima[+238 characters]",
"sentiment": 0.7579,
"highlighted_in": "main_text"
},
{
"highlight": "More detailed data can be found on the <[+48 characters]",
"sentiment": 0,
"highlighted_in": "main_text"
},
{
"highlight": "NTAP: Wells Fargo Lowers <em>NetApp</em> Price Target, Maintains Rating | NTAP Stock News",
"sentiment": 0.128,
"highlighted_in": "title"
}
]
},
{
"symbol": "NTAP",
"name": "NetApp, Inc.",
"exchange": null,
"exchange_long": null,
"country": "us",
"type": "equity",
"industry": "Technology",
"match_score": 60.574867,
"sentiment_score": 0.236729,
"highlights": [
{
"highlight": "Wells Fargo analyst Aaron Rakers has adj[+318 characters]",
"sentiment": 0.2838,
"highlighted_in": "main_text"
},
{
"highlight": "<em>NetApp</em> (NTAP, Financial) is lis[+185 characters]",
"sentiment": 0.25,
"highlighted_in": "main_text"
},
{
"highlight": "Wall Street Analysts Forecast\n\nBased on [+281 characters]",
"sentiment": -0.2732,
"highlighted_in": "main_text"
},
{
"highlight": "More detailed estimate data can be found[+326 characters]",
"sentiment": 0.5106,
"highlighted_in": "main_text"
},
{
"highlight": "Based on GuruFocus estimates, the estima[+238 characters]",
"sentiment": 0.7579,
"highlighted_in": "main_text"
},
{
"highlight": "More detailed data can be found on the <[+48 characters]",
"sentiment": 0,
"highlighted_in": "main_text"
},
{
"highlight": "NTAP: Wells Fargo Lowers <em>NetApp</em> Price Target, Maintains Rating | NTAP Stock News",
"sentiment": 0.128,
"highlighted_in": "title"
}
]
},
{
"symbol": "NTA.DE",
"name": "NetApp, Inc.",
"exchange": null,
"exchange_long": null,
"country": "de",
"type": "equity",
"industry": "Technology",
"match_score": 55.73477,
"sentiment_score": 0.236729,
"highlights": [
{
"highlight": "Wells Fargo analyst Aaron Rakers has adj[+318 characters]",
"sentiment": 0.2838,
"highlighted_in": "main_text"
},
{
"highlight": "<em>NetApp</em> (NTAP, Financial) is lis[+185 characters]",
"sentiment": 0.25,
"highlighted_in": "main_text"
},
{
"highlight": "Wall Street Analysts Forecast\n\nBased on [+281 characters]",
"sentiment": -0.2732,
"highlighted_in": "main_text"
},
{
"highlight": "More detailed estimate data can be found[+326 characters]",
"sentiment": 0.5106,
"highlighted_in": "main_text"
},
{
"highlight": "Based on GuruFocus estimates, the estima[+238 characters]",
"sentiment": 0.7579,
"highlighted_in": "main_text"
},
{
"highlight": "More detailed data can be found on the <[+48 characters]",
"sentiment": 0,
"highlighted_in": "main_text"
},
{
"highlight": "NTAP: Wells Fargo Lowers <em>NetApp</em> Price Target, Maintains Rating | NTAP Stock News",
"sentiment": 0.128,
"highlighted_in": "title"
}
]
},
{
"symbol": "0K6F.L",
"name": "NetApp, Inc.",
"exchange": null,
"exchange_long": null,
"country": "gb",
"type": "equity",
"industry": "N/A",
"match_score": 55.74558,
"sentiment_score": 0.236729,
"highlights": [
{
"highlight": "Wells Fargo analyst Aaron Rakers has adj[+318 characters]",
"sentiment": 0.2838,
"highlighted_in": "main_text"
},
{
"highlight": "<em>NetApp</em> (NTAP, Financial) is lis[+185 characters]",
"sentiment": 0.25,
"highlighted_in": "main_text"
},
{
"highlight": "Wall Street Analysts Forecast\n\nBased on [+281 characters]",
"sentiment": -0.2732,
"highlighted_in": "main_text"
},
{
"highlight": "More detailed estimate data can be found[+326 characters]",
"sentiment": 0.5106,
"highlighted_in": "main_text"
},
{
"highlight": "Based on GuruFocus estimates, the estima[+238 characters]",
"sentiment": 0.7579,
"highlighted_in": "main_text"
},
{
"highlight": "More detailed data can be found on the <[+48 characters]",
"sentiment": 0,
"highlighted_in": "main_text"
},
{
"highlight": "NTAP: Wells Fargo Lowers <em>NetApp</em> Price Target, Maintains Rating | NTAP Stock News",
"sentiment": 0.128,
"highlighted_in": "title"
}
]
}
]
},
{
"uuid": "45955f83-f983-458a-ab05-7ad44b0fc5c0",
"title": "Regeneron (REGN) Downgraded by Wells Fargo After Disappointing Drug Data | REGN Stock News",
"description": "Wells Fargo has shifted its rating on Regeneron (REGN) from Overweight to Equal Weight, setting a new price target of $580, reduced from the previous $700. This",
"keywords": "GuruFocus, Article, News, GuruFocus News, REGN",
"snippet": "Wells Fargo has shifted its rating on Regeneron (REGN, Financial) from Overweight to Equal Weight, setting a new price target of $580, reduced from the previous...",
"url": "https://www.gurufocus.com/news/2898579/regeneron-regn-downgraded-by-wells-fargo-after-disappointing-drug-data-regn-stock-news",
"image_url": "https://static.gurufocus.com/logos/0C000008R4.png?20",
"language": "en",
"published_at": "2025-05-30T14:16:32.000000Z",
"source": "gurufocus.com",
"relevance_score": null,
"entities": [
{
"symbol": "REGN.MX",
"name": "Regeneron Pharmaceuticals, Inc.",
"exchange": null,
"exchange_long": null,
"country": "mx",
"type": "equity",
"industry": "Healthcare",
"match_score": 56.98739,
"sentiment_score": 0.11404,
"highlights": [
{
"highlight": "Wall Street Analysts Forecast\n\nBased on [+312 characters]",
"sentiment": -0.2732,
"highlighted_in": "main_text"
},
{
"highlight": "More detailed estimate data can be found[+301 characters]",
"sentiment": 0,
"highlighted_in": "main_text"
},
{
"highlight": "Based on GuruFocus estimates, the estima[+266 characters]",
"sentiment": 0.8176,
"highlighted_in": "main_text"
},
{
"highlight": "More detailed data can be found on the <[+320 characters]",
"sentiment": 0,
"highlighted_in": "main_text"
},
{
"highlight": "<em>Regeneron</em> <em>Pharmaceuticals</[+332 characters]",
"sentiment": 0.0258,
"highlighted_in": "main_text"
}
]
},
{
"symbol": "REGN",
"name": "Regeneron Pharmaceuticals, Inc.",
"exchange": null,
"exchange_long": null,
"country": "us",
"type": "equity",
"industry": "Healthcare",
"match_score": 56.98063,
"sentiment_score": 0.11404,
"highlights": [
{
"highlight": "Wall Street Analysts Forecast\n\nBased on [+312 characters]",
"sentiment": -0.2732,
"highlighted_in": "main_text"
},
{
"highlight": "More detailed estimate data can be found[+301 characters]",
"sentiment": 0,
"highlighted_in": "main_text"
},
{
"highlight": "Based on GuruFocus estimates, the estima[+266 characters]",
"sentiment": 0.8176,
"highlighted_in": "main_text"
},
{
"highlight": "More detailed data can be found on the <[+320 characters]",
"sentiment": 0,
"highlighted_in": "main_text"
},
{
"highlight": "<em>Regeneron</em> <em>Pharmaceuticals</[+332 characters]",
"sentiment": 0.0258,
"highlighted_in": "main_text"
}
]
},
{
"symbol": "0R2M.L",
"name": "Regeneron Pharmaceuticals, Inc.",
"exchange": null,
"exchange_long": null,
"country": "gb",
"type": "equity",
"industry": "N/A",
"match_score": 56.977356,
"sentiment_score": 0.11404,
"highlights": [
{
"highlight": "Wall Street Analysts Forecast\n\nBased on [+312 characters]",
"sentiment": -0.2732,
"highlighted_in": "main_text"
},
{
"highlight": "More detailed estimate data can be found[+301 characters]",
"sentiment": 0,
"highlighted_in": "main_text"
},
{
"highlight": "Based on GuruFocus estimates, the estima[+266 characters]",
"sentiment": 0.8176,
"highlighted_in": "main_text"
},
{
"highlight": "More detailed data can be found on the <[+320 characters]",
"sentiment": 0,
"highlighted_in": "main_text"
},
{
"highlight": "<em>Regeneron</em> <em>Pharmaceuticals</[+332 characters]",
"sentiment": 0.0258,
"highlighted_in": "main_text"
}
]
},
{
"symbol": "REGN34.SA",
"name": "Regeneron Pharmaceuticals, Inc.",
"exchange": null,
"exchange_long": null,
"country": "br",
"type": "equity",
"industry": "Healthcare",
"match_score": 56.967438,
"sentiment_score": 0.11404,
"highlights": [
{
"highlight": "Wall Street Analysts Forecast\n\nBased on [+312 characters]",
"sentiment": -0.2732,
"highlighted_in": "main_text"
},
{
"highlight": "More detailed estimate data can be found[+301 characters]",
"sentiment": 0,
"highlighted_in": "main_text"
},
{
"highlight": "Based on GuruFocus estimates, the estima[+266 characters]",
"sentiment": 0.8176,
"highlighted_in": "main_text"
},
{
"highlight": "More detailed data can be found on the <[+320 characters]",
"sentiment": 0,
"highlighted_in": "main_text"
},
{
"highlight": "<em>Regeneron</em> <em>Pharmaceuticals</[+332 characters]",
"sentiment": 0.0258,
"highlighted_in": "main_text"
}
]
}
]
}
]
},
{
"uuid": "9dd25b33-8496-4368-8795-acf9404fde4c",
"title": "Rosen Law Firm Encourages GoHealth, Inc. Investors to Inquire About Securities Class Action Investigation - GOCO",
"description": "PR NewswireNEW YORK, May 30, 2025\n\n\n\nNEW YORK, May 30, 2025 /PRNewswire/ --",
"keywords": "GuruFocus, Article, News, PRNewswire, NAS:GOCO",
"snippet": "NEW YORK, May 30, 2025 /PRNewswire/ --\n\nWhy: Rosen Law Firm, a global investor rights law firm, continues to investigate potential securities claims on behalf o...",
"url": "https://www.gurufocus.com/news/2899399/rosen-law-firm-encourages-gohealth-inc-investors-to-inquire-about-securities-class-action-investigation-goco",
"image_url": "https://static.gurufocus.com/images/global_logo_twitter_card.png",
"language": "en",
"published_at": "2025-05-30T20:00:02.000000Z",
"source": "gurufocus.com",
"relevance_score": null,
"entities": [
{
"symbol": "GOCO",
"name": "GoHealth, Inc.",
"exchange": null,
"exchange_long": null,
"country": "us",
"type": "equity",
"industry": "Financial Services",
"match_score": 102.12555,
"sentiment_score": 0.16082,
"highlights": [
{
"highlight": "NEW YORK, May 30, 2025 /PRNewswire/ --\n\n[+337 characters]",
"sentiment": -0.128,
"highlighted_in": "main_text"
},
{
"highlight": "So What: If you purchased <em>GoHealth</[+224 characters]",
"sentiment": 0.1531,
"highlighted_in": "main_text"
},
{
"highlight": "The release stated, in pertinent part, t[+261 characters]",
"sentiment": -0.5267,
"highlighted_in": "main_text"
},
{
"highlight": "The Rosen Law Firm, P.A.\n\n275 Madison Av[+353 characters]",
"sentiment": 0.6808,
"highlighted_in": "main_text"
},
{
"highlight": "Rosen Law Firm Encourages <em>GoHealth</em>, <em>Inc</em>. Investors to Inquire About Securities Class Action Investigation - GOCO",
"sentiment": 0.6249,
"highlighted_in": "title"
}
]
}
],
"similar": [
{
"uuid": "0c5e27a1-9901-41d2-9829-15900b10361f",
"title": "Deadline Soon: Viatris Inc. (VTRS) Investors Who Lost Money Urged To Contact The Law Offices of Frank R. Cruz About Securities Fraud Lawsuit",
"description": "[url=\"]The Law Offices of Frank R. Cruz[/url] reminds investors of the upcoming June 3, 2025 deadline to participate as a lead plaintiff in the securities frau",
"keywords": "GuruFocus, Article, News, Business Wire, NAS:VTRS",
"snippet": "The Law Offices of Frank R. Cruz reminds investors of the upcomingdeadline to participate as a lead plaintiff in the securities fraud class action lawsuit filed...",
"url": "https://www.gurufocus.com/news/2899393/deadline-soon-viatris-inc-vtrs-investors-who-lost-money-urged-to-contact-the-law-offices-of-frank-r-cruz-about-securities-fraud-lawsuit",
"image_url": "https://static.gurufocus.com/images/global_logo_twitter_card.png",
"language": "en",
"published_at": "2025-05-30T20:00:02.000000Z",
"source": "gurufocus.com",
"relevance_score": null,
"entities": [
{
"symbol": "VIA.DE",
"name": "Viatris Inc.",
"exchange": null,
"exchange_long": null,
"country": "de",
"type": "equity",
"industry": "Healthcare",
"match_score": 60.64683,
"sentiment_score": -0.304913,
"highlights": [
{
"highlight": "Cruz reminds investors of the upcomingde[+354 characters]",
"sentiment": -0.6523,
"highlighted_in": "main_text"
},
{
"highlight": "On December 23, 2024, <em>Viatris</em> d[+52 characters]",
"sentiment": 0,
"highlighted_in": "main_text"
},
{
"highlight": "Then, on February 27, 2025, <em>Viatris<[+286 characters]",
"sentiment": -0.5719,
"highlighted_in": "main_text"
},
{
"highlight": "On this news, <em>Viatris</em>’ stock [+137 characters]",
"sentiment": 0.0772,
"highlighted_in": "main_text"
},
{
"highlight": "Specifically, Defendants failed to discl[+330 characters]",
"sentiment": -0.8519,
"highlighted_in": "main_text"
},
{
"highlight": "to manufacture and ship key products for[+325 characters]",
"sentiment": 0.3626,
"highlighted_in": "main_text"
},
{
"highlight": "If you purchased or otherwise acquired <[+181 characters]",
"sentiment": -0.1027,
"highlighted_in": "main_text"
},
{
"highlight": "Deadline Soon: <em>Viatris</em> <em>Inc</em>. (VTRS) Investors Who Lost Money Urged To Contact The Law Offices of Frank R. Cruz About Securities Fraud Lawsuit",
"sentiment": -0.7003,
"highlighted_in": "title"
}
]
},
{
"symbol": "VTRSV",
"name": "Viatris Inc.",
"exchange": null,
"exchange_long": null,
"country": "us",
"type": "equity",
"industry": "N/A",
"match_score": 64.440445,
"sentiment_score": -0.304913,
"highlights": [
{
"highlight": "Cruz reminds investors of the upcomingde[+354 characters]",
"sentiment": -0.6523,
"highlighted_in": "main_text"
},
{
"highlight": "On December 23, 2024, <em>Viatris</em> d[+52 characters]",
"sentiment": 0,
"highlighted_in": "main_text"
},
{
"highlight": "Then, on February 27, 2025, <em>Viatris<[+286 characters]",
"sentiment": -0.5719,
"highlighted_in": "main_text"
},
{
"highlight": "On this news, <em>Viatris</em>’ stock [+137 characters]",
"sentiment": 0.0772,
"highlighted_in": "main_text"
},
{
"highlight": "Specifically, Defendants failed to discl[+330 characters]",
"sentiment": -0.8519,
"highlighted_in": "main_text"
},
{
"highlight": "to manufacture and ship key products for[+325 characters]",
"sentiment": 0.3626,
"highlighted_in": "main_text"
},
{
"highlight": "If you purchased or otherwise acquired <[+181 characters]",
"sentiment": -0.1027,
"highlighted_in": "main_text"
},
{
"highlight": "Deadline Soon: <em>Viatris</em> <em>Inc</em>. (VTRS) Investors Who Lost Money Urged To Contact The Law Offices of Frank R. Cruz About Securities Fraud Lawsuit",
"sentiment": -0.7003,
"highlighted_in": "title"
}
]
},
{
"symbol": "VTRS",
"name": "Viatris Inc.",
"exchange": null,
"exchange_long": null,
"country": "us",
"type": "equity",
"industry": "Healthcare",
"match_score": 77.51841,
"sentiment_score": -0.304913,
"highlights": [
{
"highlight": "Cruz reminds investors of the upcomingde[+372 characters]",
"sentiment": -0.6523,
"highlighted_in": "main_text"
},
{
"highlight": "On December 23, 2024, <em>Viatris</em> d[+52 characters]",
"sentiment": 0,
"highlighted_in": "main_text"
},
{
"highlight": "Then, on February 27, 2025, <em>Viatris<[+286 characters]",
"sentiment": -0.5719,
"highlighted_in": "main_text"
},
{
"highlight": "On this news, <em>Viatris</em>’ stock [+137 characters]",
"sentiment": 0.0772,
"highlighted_in": "main_text"
},
{
"highlight": "Specifically, Defendants failed to discl[+330 characters]",
"sentiment": -0.8519,
"highlighted_in": "main_text"
},
{
"highlight": "to manufacture and ship key products for[+325 characters]",
"sentiment": 0.3626,
"highlighted_in": "main_text"
},
{
"highlight": "If you purchased or otherwise acquired <[+181 characters]",
"sentiment": -0.1027,
"highlighted_in": "main_text"
},
{
"highlight": "Deadline Soon: <em>Viatris</em> <em>Inc</em>. (VTRS) Investors Who Lost Money Urged To Contact The Law Offices of Frank R. Cruz About Securities Fraud Lawsuit",
"sentiment": -0.7003,
"highlighted_in": "title"
}
]
},
{
"symbol": "VTRS.MX",
"name": "Viatris Inc.",
"exchange": null,
"exchange_long": null,
"country": "mx",
"type": "equity",
"industry": "N/A",
"match_score": 60.636463,
"sentiment_score": -0.304913,
"highlights": [
{
"highlight": "Cruz reminds investors of the upcomingde[+354 characters]",
"sentiment": -0.6523,
"highlighted_in": "main_text"
},
{
"highlight": "On December 23, 2024, <em>Viatris</em> d[+52 characters]",
"sentiment": 0,
"highlighted_in": "main_text"
},
{
"highlight": "Then, on February 27, 2025, <em>Viatris<[+286 characters]",
"sentiment": -0.5719,
"highlighted_in": "main_text"
},
{
"highlight": "On this news, <em>Viatris</em>’ stock [+137 characters]",
"sentiment": 0.0772,
"highlighted_in": "main_text"
},
{
"highlight": "Specifically, Defendants failed to discl[+330 characters]",
"sentiment": -0.8519,
"highlighted_in": "main_text"
},
{
"highlight": "to manufacture and ship key products for[+325 characters]",
"sentiment": 0.3626,
"highlighted_in": "main_text"
},
{
"highlight": "If you purchased or otherwise acquired <[+181 characters]",
"sentiment": -0.1027,
"highlighted_in": "main_text"
},
{
"highlight": "Deadline Soon: <em>Viatris</em> <em>Inc</em>. (VTRS) Investors Who Lost Money Urged To Contact The Law Offices of Frank R. Cruz About Securities Fraud Lawsuit",
"sentiment": -0.7003,
"highlighted_in": "title"
}
]
}
]
},
{
"uuid": "b6b6b7e2-6e82-400e-8fb1-1aa0a4535fa8",
"title": "DEADLINE ALERT for WST, DMRC, CODI, ELV: Law Offices of Howard G. Smith Reminds Investors of Opportunity to Lead Securities Fraud Class Actions",
"description": "BENSALEM, Pa., May 30, 2025 (GLOBE NEWSWIRE) -- Law Offices of Howard G. Smith reminds investors that class action lawsuits have been filed on behalf of share",
"keywords": "GuruFocus, Article, News, Marketwired, WST, DMRC, CODI, ELV",
"snippet": "BENSALEM, Pa., May 30, 2025 (GLOBE NEWSWIRE) -- Law Offices of Howard G. Smith reminds investors that class action lawsuits have been filed on behalf of shareho...",
"url": "https://www.gurufocus.com/news/2899313/deadline-alert-for-wst-dmrc-codi-elv-law-offices-of-howard-g-smith-reminds-investors-of-opportunity-to-lead-securities-fraud-class-actions",
"image_url": "https://static.gurufocus.com/images/global_logo_twitter_card.png",
"language": "en",
"published_at": "2025-05-30T19:00:03.000000Z",
"source": "gurufocus.com",
"relevance_score": null,
"entities": [
{
"symbol": "DMRC",
"name": "Digimarc Corporation",
"exchange": null,
"exchange_long": null,
"country": "us",
"type": "equity",
"industry": "Technology",
"match_score": 29.222824,
"sentiment_score": -0.31205,
"highlights": [
{
"highlight": "<em>Digimarc</em> <em>Corporation</em> ([+330 characters]",
"sentiment": -0.802,
"highlighted_in": "main_text"
},
{
"highlight": "as a result, <em>Digimarc</em> would ren[+328 characters]",
"sentiment": 0.1779,
"highlighted_in": "main_text"
}
]
},
{
"symbol": "WST",
"name": "West Pharmaceutical Services, Inc.",
"exchange": null,
"exchange_long": null,
"country": "us",
"type": "equity",
"industry": "Healthcare",
"match_score": 25.87659,
"sentiment_score": -0.733,
"highlights": [
{
"highlight": "<em>West</em> <em>Pharmaceutical</em> <e[+351 characters]",
"sentiment": -0.733,
"highlighted_in": "main_text"
}
]
}
]
},
{
"uuid": "dc976ceb-edf8-4a39-9f1f-0dde1ae57795",
"title": "SelectQuote, Inc. Investor News: If You Have Suffered Losses in SelectQuote, Inc. (NYSE: SLQT), You Are Encouraged to Contact The Rosen Law Firm About Your Rights",
"description": "NEW YORK, May 30, 2025 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, announces an investigation of potential securities claims",
"keywords": "GuruFocus, Article, News, Marketwired, SLQT",
"snippet": "NEW YORK, May 30, 2025 (GLOBE NEWSWIRE) --\n\nWHY: Rosen Law Firm, a global investor rights law firm, announces an investigation of potential securities claims on...",
"url": "https://www.gurufocus.com/news/2899020/selectquote-inc-investor-news-if-you-have-suffered-losses-in-selectquote-inc-nyse-slqt-you-are-encouraged-to-contact-the-rosen-law-firm-about-your-rights",
"image_url": "https://static.gurufocus.com/images/global_logo_twitter_card.png",
"language": "en",
"published_at": "2025-05-30T18:00:05.000000Z",
"source": "gurufocus.com",
"relevance_score": null,
"entities": [
{
"symbol": "SLQT",
"name": "SelectQuote, Inc.",
"exchange": null,
"exchange_long": null,
"country": "us",
"type": "equity",
"industry": "Financial Services",
"match_score": 155.89268,
"sentiment_score": 0.0707,
"highlights": [
{
"highlight": "NEW YORK, May 30, 2025 (GLOBE NEWSWIRE) [+328 characters]",
"sentiment": 0.4019,
"highlighted_in": "main_text"
},
{
"highlight": "SO WHAT: If you purchased <em>SelectQuot[+227 characters]",
"sentiment": 0.1531,
"highlighted_in": "main_text"
},
{
"highlight": "The release stated, in pertinent part, t[+270 characters]",
"sentiment": -0.5267,
"highlighted_in": "main_text"
},
{
"highlight": "On this news, <em>SelectQuote</em> stock[+257 characters]",
"sentiment": 0.8519,
"highlighted_in": "main_text"
},
{
"highlight": "<em>SelectQuote</em>, <em>Inc</em>. Investor News: If You Have Suffered Losses in <em>SelectQuote</em>, <em>Inc</em>. (<em>NYSE</em>: <em>SLQT</em>), You Are Encouraged to Contact The Rosen Law Firm About Your Rights",
"sentiment": -0.5267,
"highlighted_in": "title"
}
]
}
]
}
]
},
{
"uuid": "0db241ff-06c7-41b3-9a18-fa6b1ef14eb9",
"title": "CGC Deadline: CGC Investors with Losses in Excess of $100K Have Opportunity to Lead Canopy Growth Corporation Securities Fraud Lawsuit",
"description": "PR NewswireNEW YORK, May 30, 2025\n\n\n\nNEW YORK, May 30, 2025 /PRNewswire/ -- Rosen Law Firm, a global investor rights law firm, reminds purchasers of securitie",
"keywords": "GuruFocus, Article, News, PRNewswire, NAS:CGC",
"snippet": "NEW YORK, May 30, 2025 /PRNewswire/ -- Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Canopy Growth Corporation (NASDAQ:...",
"url": "https://www.gurufocus.com/news/2899395/cgc-deadline-cgc-investors-with-losses-in-excess-of-100k-have-opportunity-to-lead-canopy-growth-corporation-securities-fraud-lawsuit",
"image_url": "https://static.gurufocus.com/images/global_logo_twitter_card.png",
"language": "en",
"published_at": "2025-05-30T20:00:02.000000Z",
"source": "gurufocus.com",
"relevance_score": null,
"entities": [
{
"symbol": "CGC",
"name": "Canopy Growth Corporation",
"exchange": null,
"exchange_long": null,
"country": "us",
"type": "equity",
"industry": "Healthcare",
"match_score": 109.92767,
"sentiment_score": -0.006129,
"highlights": [
{
"highlight": "NEW YORK, May 30, 2025 /PRNewswire/ -- R[+311 characters]",
"sentiment": 0.4588,
"highlighted_in": "main_text"
},
{
"highlight": "So What: If you purchased <em>Canopy</em[+297 characters]",
"sentiment": 0.6705,
"highlighted_in": "main_text"
},
{
"highlight": "Details of the case: According to the la[+206 characters]",
"sentiment": -0.7269,
"highlighted_in": "main_text"
},
{
"highlight": "(\"Claybourne\") pre-rolled joints in conn[+335 characters]",
"sentiment": -0.5994,
"highlighted_in": "main_text"
},
{
"highlight": "To join the <em>Canopy</em> <em>Growth</[+302 characters]",
"sentiment": 0,
"highlighted_in": "main_text"
},
{
"highlight": "Rosen Law Firm, P.A.\n\n275 Madison Avenue[+387 characters]",
"sentiment": 0.6808,
"highlighted_in": "main_text"
},
{
"highlight": "CGC Deadline: CGC Investors with Losses in Excess of $100K Have Opportunity to Lead <em>Canopy</em> <em>Growth</em> <em>Corporation</em> Securities Fraud Lawsuit",
"sentiment": -0.5267,
"highlighted_in": "title"
}
]
}
],
"similar": [
{
"uuid": "f9d8a820-9495-481c-9fbe-6d3fa1f2d4c9",
"title": "TMCI Deadline: TMCI Investors with Losses in Excess of $100K Have Opportunity to Lead Treace Medical Concepts, Inc. Securities Fraud Lawsuit",
"description": "PR NewswireNEW YORK, May 30, 2025\n\n\n\nNEW YORK, May 30, 2025 /PRNewswire/ --",
"keywords": "GuruFocus, Article, News, PRNewswire, NAS:TMCI",
"snippet": "NEW YORK, May 30, 2025 /PRNewswire/ --\n\nWhy: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Treace Medical Concepts, Inc...",
"url": "https://www.gurufocus.com/news/2899397/tmci-deadline-tmci-investors-with-losses-in-excess-of-100k-have-opportunity-to-lead-treace-medical-concepts-inc-securities-fraud-lawsuit",
"image_url": "https://static.gurufocus.com/images/global_logo_twitter_card.png",
"language": "en",
"published_at": "2025-05-30T20:00:02.000000Z",
"source": "gurufocus.com",
"relevance_score": null,
"entities": [
{
"symbol": "TMCI",
"name": "Treace Medical Concepts, Inc.",
"exchange": null,
"exchange_long": null,
"country": "us",
"type": "equity",
"industry": "Healthcare",
"match_score": 210.33865,
"sentiment_score": 0.2043,
"highlights": [
{
"highlight": "NEW YORK, May 30, 2025 /PRNewswire/ --\n\n[+326 characters]",
"sentiment": 0.4588,
"highlighted_in": "main_text"
},
{
"highlight": "The Rosen Law Firm, P.A.\n\n275 Madison Av[+422 characters]",
"sentiment": 0.6808,
"highlighted_in": "main_text"
},
{
"highlight": "<em>TMCI</em> Deadline: <em>TMCI</em> Investors with Losses in Excess of $100K Have Opportunity to Lead <em>Treace</em> <em>Medical</em> <em>Concepts</em>, <em>Inc</em>. Securities Fraud Lawsuit",
"sentiment": -0.5267,
"highlighted_in": "title"
}
]
}
]
},
{
"uuid": "3e0ab650-50a3-4f40-9506-4bf22de288b7",
"title": "BigBear.ai Holdings (NYSE: BBAI) Deadline Approaching: Berger Montague Advises Investors of Deadline in Securities Fraud Lawsuit",
"description": "PR NewswirePHILADELPHIA, May 30, 2025\n\n\n\nPHILADELPHIA, May 30, 2025 /PRNewswire/ -- Berger Montague PC advises investors that a securities class action lawsui",
"keywords": "GuruFocus, Article, News, PRNewswire, NYSE:BBAI",
"snippet": "PHILADELPHIA, May 30, 2025 /PRNewswire/ -- Berger Montague PC advises investors that a securities class action lawsuit has been filed against BigBear.ai Holding...",
"url": "https://www.gurufocus.com/news/2898679/bigbearai-holdings-nyse-bbai-deadline-approaching-berger-montague-advises-investors-of-deadline-in-securities-fraud-lawsuit",
"image_url": "https://static.gurufocus.com/images/global_logo_twitter_card.png",
"language": "en",
"published_at": "2025-05-30T15:00:04.000000Z",
"source": "gurufocus.com",
"relevance_score": null,
"entities": [
{
"symbol": "GIGGU",
"name": "GigCapital4, Inc.",
"exchange": null,
"exchange_long": null,
"country": "us",
"type": "equity",
"industry": "Financial Services",
"match_score": 26.051064,
"sentiment_score": 0.4019,
"highlights": [
{
"highlight": "In June 2021, BigBear.ai Holdings entere[+270 characters]",
"sentiment": 0.4019,
"highlighted_in": "main_text"
}
]
},
{
"symbol": "GIG",
"name": "GigCapital4, Inc.",
"exchange": null,
"exchange_long": null,
"country": "us",
"type": "equity",
"industry": "Financial Services",
"match_score": 26.051064,
"sentiment_score": 0.4019,
"highlights": [
{
"highlight": "In June 2021, BigBear.ai Holdings entere[+270 characters]",
"sentiment": 0.4019,
"highlighted_in": "main_text"
}
]
},
{
"symbol": "GIGGW",
"name": "GigCapital4, Inc.",
"exchange": null,
"exchange_long": null,
"country": "us",
"type": "equity",
"industry": "N/A",
"match_score": 26.05106,
"sentiment_score": 0.4019,
"highlights": [
{
"highlight": "In June 2021, BigBear.ai Holdings entere[+270 characters]",
"sentiment": 0.4019,
"highlighted_in": "main_text"
}
]
}
]
}
]
},
{
"uuid": "621c62ae-7d27-481a-bf99-29955035c241",
"title": "Johnson Fistel Investigates Quantum Computing: Long Term Investors Encouraged to Reach Out",
"description": "Johnson Fistel, PLLP, a shareholder rights law firm, announces it is investigating potential breaches of fiduciary duties by certain directors and officers of",
"keywords": "GuruFocus, Article, News, Business Wire, NAS:QUBT",
"snippet": "Johnson Fistel, PLLP, a shareholder rights law firm, announces it is investigating potential breaches of fiduciary duties by certain directors and officers of Q...",
"url": "https://www.gurufocus.com/news/2899398/johnson-fistel-investigates-quantum-computing-long-term-investors-encouraged-to-reach-out",
"image_url": "https://static.gurufocus.com/images/global_logo_twitter_card.png",
"language": "en",
"published_at": "2025-05-30T20:00:02.000000Z",
"source": "gurufocus.com",
"relevance_score": null,
"entities": [
{
"symbol": "QUBT",
"name": "Quantum Computing, Inc.",
"exchange": null,
"exchange_long": null,
"country": "us",
"type": "equity",
"industry": "Technology",
"match_score": 68.65906,
"sentiment_score": -0.049,
"highlights": [
{
"highlight": "Johnson Fistel, PLLP, a shareholder righ[+296 characters]",
"sentiment": 0.2732,
"highlighted_in": "main_text"
},
{
"highlight": "Recently a class action complaint was fi[+337 characters]",
"sentiment": -0.802,
"highlighted_in": "main_text"
},
{
"highlight": "Johnson Fistel Investigates <em>Quantum</em> <em>Computing</em>: Long Term Investors Encouraged to Reach Out",
"sentiment": 0.3818,
"highlighted_in": "title"
}
]
},
{
"symbol": "MMMM",
"name": "Quad M Solutions, Inc.",
"exchange": null,
"exchange_long": null,
"country": "us",
"type": "equity",
"industry": "Financial Services",
"match_score": 36.654785,
"sentiment_score": 0.4803,
"highlights": [
{
"highlight": "2) Defendants overstated the scope and n[+333 characters]",
"sentiment": 0.5994,
"highlighted_in": "main_text"
},
{
"highlight": "<em>M</em> <em>Solutions</em>, <em>Inc</[+347 characters]",
"sentiment": 0.3612,
"highlighted_in": "main_text"
}
]
}
],
"similar": []
}
]
}
Sentiment
Live response for past 24 hours
{
"meta": {
"returned": 1,
"limit": 10
},
"data": [
{
"key": "us",
"total_documents": 3292,
"sentiment_avg": 0.2951030297745066
}
]
}
Other details
Entity count
- 32,649